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It has been hypothesized that an increase in the ratio of plasma tryptophan (1RP) to 
branched-chain amino acid (BCAA) concentrations may mediate an increase in 
cerebral serotonin synthesis, through an increased cerebral tryptophan uptake. It is 
postulated that the increased brain serotonin content may induce central fatigue-
during prolonged exercise. Until present, this postulate had not been subject to 
rigorous scientific testing during prolonged exercise. Therefore the aim of this study 
was to investigate whether ingesting a BCAA supplement during prolonged exercise 
improves physical performance and central fatigue. The use of such a supplement 
during prolonged exercise could then be expected to have a large effect on 
performance. Eight trained cyclists (V02 max= 61.9 ± 4.3 ml 02/kg/min) ingested, 
in random order, a drink containing either 10% carbohydrate (CHO), 10% CHO and 
0.16% branched-chain amino acid (BCAA) or 0.16% BCAA. Every hour, for the 
duration of the exercise (4 hours, 55% V02 max) blood samples were analysed for 
amino acids, ammonia, free fatty acids, glycerol, glucose and insulin concentrations. 
Urine was analysed for urea and creatinine concentrations. Heart rate, oxygen 
consumption (V02), respiratory exchange ratio (RER) and rating of perceived 
exertion were also analysed. Thereafter, subject's 40km time trial performance and 
RPE was assessed on a Velodyne windtrainer. Central fatigue following the time 
trial was quantified using the Sternberg reaction-time paradigm. The serum 
concentration of the BCAA's declined as a result of the exercise, in the BCAA only 
trial. Tryptophan concentration, however, did not change during the exercise. The 
serum TRP:BCAA ratio increased (0.16 ± 0.06 to 0.20 ± 0.10; p~0.05) in the CHO 
trial only. The BCAA trial differed from the two trials in which CHO was ingested 
because plasma ammonia and glucose concentrations did not increase, while free 
fatty acids (FF A's) and glycerol concentrations increased significantly (p~0.05). The 
lower RER in the BCAA trials suggests a higher proportion of fat was oxidised in 
these trials, compared to the other two trials. Cycling performance, over a 40km time 
trial, (CHO= 68.59 ± 6.02; CHO+ BCAA = 68.00 ± 3.01; BCAA = 69.43 ± 5.35 
min/sec), ratings of perceived exertion, submaximal or maximal heart rates, and 
mental performance were not different between trials. Data from this study appears 
to refute the thesis hypothesis that an increase in serum TRP:BCAA decreases 
physical performance and central fatigue, during prolonged exercise. 
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Chapter 1 - Motivation and Aims of the Study 
1.1 Introduction: 
For many years.physiologists have used physical exercise as a model to study many 
perturbations of homeostasis. Fatigue following prolonged exercise, in particular, 
has enjoyed much attention as it serves as a model to investigate many physiological 
mechanisms. Fatigue is a complex phenomenon, and is defined physiologically as 
the inability to maintain power output. Fatigue may also occur, however, as a result 
of trauma and its aetiology is therefore as important to the clinician as it is to the elite 
athlete (Newsholme et al., 1992). 
The inability to maintain a particular power output over time, results from continuous 
muscle movement during prolonged endurance exercise. This phenomenon, known 
as fatigue, may be initiated by any one of a number of different processes, either 
central or peripheral, and may result in a decline in the maximal velocity of muscle 
contraction, a reduction in peak isometric force, tremor or in an inability to sustain an 
expected submaximal force or velocity (Green, 1987). 
~ ~.----- lmotmition/drive! 
CENTRAL I 
t------1 reflex curve I 
.-L-----~ 
<J--------1 neuromuscular tr.ms I 
<J----1 acwn JK]tmtial I 
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FIGURE 1.1 Current summary of the proposed "command chain" initiating muscular contraction in man 
and the possible sites at which fatigue may occur (from Edwards, p3, 1981). (neuromuscular trans = 
neuromuscular transmission). 
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Tue aetiology of fatigue has long been perceived as a failure somewhere in the 
'command chain' that results in a muscle contraction. This 'command chain' is 
initiated in the brain where the subconscious decision to produce a muscle 
contraction is made, and it ends with the production of force, as a result of cross 
bridge interaction in the myofibrils of the muscle recruited (Edwards, 1983, Fig 1.1). 
Figure 1.1 illustrates that centrally, fatigue may occur either from a decline in 
motivation or drive, occurring in the brain, or from a decrease in the activity of spinal 
reflexes. Peripheral fatigue occurs in the muscle, and one of four possible 
mechanisms have been implicated in its production: i) a decline in neuromuscular 
transmission, between nerves and muscle, ii) a reduced activity of action potentials at 
the T-tubules, iii) decreased responsiveness of the T-tubules to excitation, or iv) 
failure of released calcium to produce muscular contraction. It has been suggested 
that the initiation of fatigue may be a protective mechanism, preventing irreparable 
muscle damage (Noakes, 1988). 
Green (1987) suggests that in certain instances fatigue may be initiated in the brain 
itself or within the central nervous system. In this case fatigue is brought about by a 
modification in supraspinal centre output, either by neurally mediated afferent 
feedback from muscle or by the passage of blood-borne substances across the blood 
brain barrier (Green, 1987). 
In accordance with this it has recently been proposed that an alteration in blood 
amino acid concentration may cause fatigue (Parry-Billings et al., 1990, Blomstrand 
et al., 1991; Bailey et al., 1992; Wilson and Maughan, 1992). These authors propose 
that the decline in plasma branched-chain amino acids (BCAA) during prolonged 
exercise, leads to an alteration in the tryptophan (TRP) to BCAA ratio (TRP:BCAA). 
As a result of this alteration in TRP:BCAA, additional tryptophan is transported into 
the brain through the blood-brain barrier (Yuwiler et al., 1977), and the increased 
cerebral tryptophan is then hydroxylated and decarboxylated into serotonin 
(Fernstrom, 1974; Blomstrand et al., 1991). Consequently, serotonin content in 
certain brain neurones increases (Parry- Billings et al., 1990; Newsholme et al., 
1991 ), and it is this increased serotonin concentration that is thought to increase the 
athlete's perception of effort (Newsholme et al., 1991), and thereby impair 
performance during prolonged exercise. 
It is further believed that the increased serotonin concentration may also induce 
mental fatigue, decreasing the ability to concentrate. This hypothesis has already 
been described in the lay press (Pine, 1983; Berg, 1983), and as a result athletes are 
aware of the possibility that diet may have profound effects on behaviours as varied 
as mood, sleep, physical and mental performance. 
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The theory, that an increased serum TRP:BCAA, and an increased cerebral serotonin 
concentration might cause fatigue has, however, not been subject to rigorous 
scientific testing. To date studies investigating this hypothesis have either been 
conducted in the field, where stringent controls were not possible (Blomstrand et 
al.,1991) or in the laboratory where serotonin concentrations were pharmacologically 
altered (Bailey et al,. 1992; Wilson and Maughan, 1992; Bailey et al., 1993). 
Many questions are, however, still unanswered and we therefore felt that a carefully 
controlled laboratory investigation was required to further investigate the hypothesis 
(For a complete description of these issues see section 2.3) 
1.2 Aims of the thesis. 
The following -study was designed to answer the following questions: 
i) Do serum BCAA concentrations decrease during prolonged endurance 
exercise as has been previously described in the literature? 
ii) Does the ingestion of a BCAA supplement during prolonged exercise prevent 
the decrease in serum BCAA concentration? 
iii) Does the maintenance of the serum TRP:BCAA during prolonged exercise 
influence either physical or mental performance? 
Another important component of this study was to develop the techniques necessary 
to rapidly and accurately analyse serum for amino acid concentrations, using high 
performance liquid chromatography (HPLC). 
1.3 Thesis hypothesis. 
In this thesis the following hypothesis was tested: During prolonged submaxirnal 
exercise serum BCAA concentrations decrease, causing an increase in serum 
TRP:BCAA, which decreases power output and mental alertness. Ingesting a BCAA 
supplement during the prolonged exercise maintains the serum TRP:BCAA, power 
output and mental alertness, as measured by a 40 km time trial and by the Sternberg 
reaction-time paradigm. 
Chapter 2- Literature Review 
The following review describes the evolution of the hypothesis and pertinent amino 
acid chemistry. This is followed by a description of alterations in plasma/serum 
TRP:BCAA concentrations induced by diet and exercise, and finally those studies 
that have specifically addressed the hypothesis will be described. 
2.1 Amino Acids & Serotonin: 
2.1.1 Introduction. 
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Twenty amino acids are common, and may be grouped according to charge and 
polarity. The variable component (R group) ·of an amino acid confers certain 
characteristics to the molecule, and it is on the basis of this R group that the amino 
acid is classified (see Table 2.1). When the R group ionises, the amino acid is either 
basic (if positively charged), or acidic (if negatively charged). The ionic and polar 
nature of amino acids is important as it provides us with the ability to separate these 
molecules using high performance liquid chromatography (HPLC). This will 
become relevant in chapter 3 when the technique of the HPLC system is discussed. 
Branched-chain amino acids 
The BCAA's (valine, isoleucine and leucine) are three often essential amino acids 
that cannot be synthesised by the human body, and are therefore required in the diet. 
Metabolism of the BCAA's is unique among amino acids and particular interest has 
been paid to the possibility that: 
i) Branched-chain amino acids, ·through competition with the large 
neutral amino acids ( especially tryptophan) for transport across the 
blood-brain barrier, appear to play a role in controlling brain amino 
acid concentrations and thereby the synthesis of amino acid-derived 
neurotransmitters, such as serotonin, dopamine and norepinephrine 
(Pardridge, 1977), 
ii) The initial enzymes in the catabolism ofBCAA's are unregulated, that 
is, reaction kinetics are governed purely by enzyme and substrate 
concentrations (Harper et al., 1984), and 
iii) The BCAA's appear to exert specific regulatory effects on tissue 
protein degradation and synthesis which may have clinical relevance 
(Harper et al., 1984). 
Biochemistry of tryptophan 
The aromatic amino acid tryptophan, like 
the BCAA's, is essential and cannot be 
synthesised by the human body. In 
addition, tryptophan is the least abundant 
of all amino acids found in food. At rest, 
some 80% (McMenamy and Oncley, 1958; 
Fernstrom & Wurtman, 1974b) to 90% 
(Chaouloff, 1991) of the plasma tryptophan 
is found bound to the plasma protein 
albumin. The hydroxylation and 
decarboxylation oftryptophan in the brain 
leads to the production of 5-
hydroxytryptamine (serotonin). 
Biochemistry of serotonin. 
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TABLE 2.1 The essential amino acids and 
their classification. 
Amino acid Classification 
1) Valine Branched-chain 
2) Leucine Branched-chain 
3) Isoleucine Branched-chain 
4) Threonine Hydroxyl 
5) Methionine Sulphur 
6) Phenylalanine Aromatic 
7) Tryptophan Aromatic 
8) Histidine Basic 
9) Lysine Imino 
1 O)Arginine Basic 
Serotonin is a ubiquitous neurotransmitter found in the certain brain neurones 
(hypothalamus and basal ganglia). It has been implicated in a number of 
physiological and behavioural processes in vertebrates, but does not appear to be 
essential for any of them (Jacobs and Azmitia, 1992). This is explained by the fact 
the expansive system of serotonergic neurones exert a tonic modulatory effect on its 
widespread targets. 
REGULATION OF SEROTONIN 
It appears that there are at least two pools of serotonin within the pre-synaptic 
terminals (Aprison and Hingten, 1972). One is firmly bound and increases directly 
through synthesis of this amine. The second is a smaller labile-bound pool which 
directly affects the amount of transmitter liberated in the synaptic junction or 
deaminated by monoamine oxidase in the mitochondria. As the amine is released by 
the labile-bound pool, it exerts its effect as a free pool, until it is inactivated through 
diffusion and uptake into the pre-synaptic terminal or the post-synaptic terminal or is 
desensitised. The physiologically effective serotonin pool is the sum of both the free 
and labile-bound pools. The predominant action of serotonin is related to motor 
activity and to the wake-sleep-arousal cycle of vertebrates (Jacobs and Azmitia, 
1992). 
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THE ROLE OF SEROTONIN IN SLEEP 
Serotonin plays an important role in the initiation of sleep in experimental animals. 
Studies have illustrated 'how the loss of serotonin in the brain, either by ablation of 
the raphe nuclei or by administration of serotonin receptor blockers, results in the 
loss of slow wave sleep time, which is proportional to the decline in serotonin 
concentrations (Aprison and Hingten, 1972). Ashley and Leathwood (1983) 
hypothesised that a 500mg dose oftryptophan in humans, which increased the 
TRP:BCAA was sufficient to alter brain serotonin concentrations. The influence this 
dose of tryptophan had on the nature of sleep patterns was investigated in humans 
(Pollet and Leathwood, 1983). Despite the superficiality of this study, with 
subjective scores assigned to the night's sleep these authors demonstrated a decreased 
latency and a better night's sleep following the ingestion of tryptophan. Young 
(1986) has stated that an increase in the serum concentration of serotonin produces a 
feeling of tiredness and sleepiness in both man and experimental animals. This is 
supported by Wurtman (1983), who has shown that the ingestion of a single dose of 
tryptophan significantly increased self reported levels of fatigue/inertia and decreased 
levels of vigour/activity. On the basis of these observations Newsholme et al. (1991) 
suggested that an increase in the concentration of serotonin, in certain areas of the 
brain, could increase the sensitivity of the brain to fatigue. It follows therefore that 
any process resulting in an increased cerebral serotonin concentration could induce 
central fatigue. 
2.1.2 Plasma amino acid concentrations. 
In the present study serum amino aids conce!ltrations were determined, while most 
other authors refer to plasma concentrations. 
Resting plasma amino acid concentrations reflect the balance between the utilisation 
of amino acids and their input from: 
i) Release of dietary amino acids from ingested proteins from the hepatic portal 
system into the systemic blood supply, 
ii) Amino acid release from, and prote4:i turnover, in tissues and 
iii) The uptake of amino acids from the blood to the tissues where ~y are used 
for protein synthesis, or deaminated to urea in the liver (Harper, 1968). 
Total plasma amino concentrations vary rhythmically during the course of a 24 hour 
day (Feign et al., 1967). The mechanism for this rhythmicity is unclear, but is 
probably related to changes in amino acid pool sizes as a result of dietary and/or 
hormonal changes (Wurtman et al. 1968). 
Changes in BCAA concentration 
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Under normal conditions plasma amino acid concentrations in humans tend to be 
proportional to protein intake (Frame, 195 8), and the nutritive value of an ingested 
protein depends upon its absorption, in the form of amino acids. While ingested 
plasma amino acid concentrations may be ten-fold greater than the amounts of amino 
acid present in the extracellular space, plasma amino acid concentrations fluctuate by 
only 50% (Scriver et al., 1971). The authors suggest that liver and skeletal muscle 
play a central role in the maintenance of constant plasma amino acid concentrations. 
Of the total amino acid release from extrahepatic tissues, 50% is alanine and 
glutamine (Harper et al., 1984 ). This alanine forms the primary vehicle of amino 
acid nitrogen (NH2) transport from peripheral tissues to the liver (Scriver et al., 
1971). In the liver, this amino acid is deaminated to form urea and the resultant 
pyruvate is converted to glucose via gluconeogenesis, in the muscle (Goldstein and 
Newsholme, 1976). 
Regulation of BCAA metabolism 
Following a meal high in protein plasma BCAA concentrations increase and tend to 
remain high while other amino acids fall to control levels after the increased protein 
intake. This suggests that the BCAA degrading enzymes do not adapt to the high 
BCAA levels and that their capacity for oxidising BCAA's is exceeded during 
periods of increased protein intake. Calculations by Harper et al. (1984) however 
suggest that it is unlikely that these enzymes become limiting. For example, BCAA 
intake of a 150g rat increases by 5000 µmol when the dietary protein intake increases 
by 20 to 30%, over standard dietary levels, yet the increase in the body's BCAA pool 
is only 100 µmol. These authors suggest that some factor, other than a limited 
oxidative capacity is responsible for the elevated BCAA pools in rats adapted to a 
high protein intake. 
Insulin appears to play an important role in plasma BCAA regulation. Intravenous . 
insulin infusion stimulates leucine uptake and oxidation by peripheral muscles. 
Amburand et al. (1982) found that insulin infusions elevated plasma BCAA 
concentrations in dogs moderately starved for up to two weeks. Lowered circulating 
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insulin and higher glucagon concentrations, seen in starvation, produces a decrease in 
plasma BCAA concentration. Periods of starvation can also alter the rate of protein 
degradation, resulting in higher BCAA levels (Pozefsky et al., 1976). 
Changes in tryptophan and serotonin concentrations 
In contrast to the BCAA's, tryptophan concentrations are less likely to fluctuate as 
this amino acid is not taken up into skeletal muscle (Harper et al., 1984), not even 
under the influence of insulin (Fernstrom and Wurtman, 1974a). Plasma tryptophan 
concentrations show a circadian rhythm, with the peak at midnight and the nadir in 
the early morning, and brain serotonin concentrations exhibit similar, but delayed 
rhythms (Fernstrom and Wurtman, 1974b). 
Brain serotonin concentrations are also influenced by meal content (Fernstrom, 1974; 
Berg, 1983), through changes in,plasma tryptophan. While a meal high in 
carbohydrate has no effect on total plasma tryptophan, but increases cerebral 
serotonin, a high protein meal decreases both plasma and cerebral serotonin 
concentration (Fernstrom and Wurtman, 1972; Fernstrom, 1974; Perez-Cruet et al., 
1974; Wurtman, 1983). The insulin released following a high carbohydrate meal 
increases tissue absorption of most amino acids, including the BCAA's, but as insulin 
does not increase muscle absorption of tryptophan, the total plasma tryptophan 
content does not change. The resultant decrease in plasma BCAA concentration 
effects an increase in tryptophan transport into the brain and an acceleration of brain 
serotonin synthesis. However, the opposite occurs following a protein meal, where 
plasma BCAA concentrations increase, thereby decreasing the transport of 
tryptophan into the brain for serotonin synthesis (see amino acid transport - section 
2.15). Hence, cerebral serotoni~ content mirrors changes seen in plasma tryptophan 
concentrations. 
2.1.3 Amino acid transport across cell membranes 
Amino acids are actively transported across the cell membranes of most tissues via 
carriers. These protein macromolecules, which extend across the entire membrane, 
are specific for the different classes of amino acids. Active transport of amino acids 
from the mucosal to the serosal side of enterocytes occurs in the small intestine 
(Larsen et al., 1964; Nixon and Mawer, 1970). Active transport also occurs in 
muscle and the brain 
Intestine 
In the small intestine 5 distinct amino acid transport systems have now been 
identified for neutral, basic, acidic, iminoglycine and n-methylated (for example, 
sarcosine and betaine) amino acids. Each depends on the sodium concentration 
gradient, from the extracellular to the intracellular fluid space, to 'drive' the uphill 
transport of amino acids against their concentration gradient (Adibi, 1970). Similar 
carriers occur in the blood-brain barrier, but the affinity of the carriers for amino 
acids is between 10 and 20 times higher than the intestinal carriers. 
Muscle 
Very little work has been conducted on the kinetics of amino acid uptake into 
muscle. Pardridge (1977), however, has shown that the muscle amino acid carriers 
are similar to those in the gut, that is, low affinity, high capacity. 
Brain 
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At the blood-brain barrier an amino acid is transported by one of three carrier 
systems. Each carrier protein has a specific affinity for either neutral, basic or acidic 
amino acids. Large neutral amino acids are transported by the 'L system' carrier, and 
uptake is stereospecific, with the L-enantiomer having the greatest affinity 
(Oldendorf, 1973). This carrier is in equilibrium, that is, it does not concentrate the 
amino acids against a concentration gradient and is sodium independent. The km 
values approximate plasma levels, which means that the rate of neutral amino acid 
transport across the blood-brain barrier is likely to be sensitive to changes in plasma 
amino acid concentration (Harper et al., 1984). Phenylalanine, tyrosine, leucine, 
isoleucine, methionine, tryptophan, histidine, valine, threonine, cysteine, glutamine, 
asparagine and serine are transported by this carrier. Newsholme and Leech (1984) 
have shown that the L-system carrier has the highest affinity for leucine, isoleucine, 
valine, phenylalanine and tyrosine. The other two basic and acidic amino acid 
carriers show no affinity for these amino acids (Oldendorf and Szabo, 1976). 
Transport of tryptophan across the blood-brain barrier 
Tryptophan transport into the brain depends on the extent to which it is bound to 
plasma albumin (McMenamy, 1965), and this has important consequences in altering 
tryptophan's transport. The existence ofthis "albumin-bound" reservoir of 
tryptophan in the bloodstream gives this amino acid a competitive advantage over 
other neutral amino acids with respect to transport from the blood stream into the 
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brain (Fernstrom & Wurtman, 1974a). For example, following carbohydrate 
ingestion the plasma insulin concentration increases and promotes the absorption of 
all amino acids, except tryptophan, into peripheral tissues. As a result of this 
phenomenon the competition between tryptophan and the other neutral amino acids 
for transport into the b~ain is decreased and that is thought to increase the 
concentration of cerebral tryptophan and serotonin synthesis. 
Competition for transport 
Competition exists between the BCAA's and tryptophan, at the blood-brain barrier 
(Fig 2.1). It is still debated though, whether it is the free or total plasma tryptophan 
concentration that determines its transport into the brain. 
!PLASMA TRYPTOPHAN !PLASMA BCAA 
¥ 
TRP:BCAA RA TIO 
BRAIN TRYPTOPHA 
I s·EROTONIN I 
FIGURE 2.1 Competition exists at the level of the blood-brain barrier between the BCAA 's and 
tryptophan for entry into the brain. Any tryptophan transported into the brain is converted into 
serotonin in a dose-dependent manner. Any mechanism altering serum TRP:BCAA is thought to 
influence the cerebral serotonin concentration (based on Yuwiler et al., 1977). 
Chaouloff et al. (1986) showed in rats running for two hours at 20 m/min, that 
although total plasma tryptophan concentration did not change, plasma free 
tryptophan concentration increased as a result of competition with FF A for albumin 
binding sites. Nor was there any difference in the concentrations of the other large 
neutral amino acids (LNAA). Brain tryptophan concentration, however, increased by 
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80% implying that free, rather than total plasma tryptophan concentration,
 dictates 
the change in cerebral tryptophan concentration. Similar changes have bee
n 
described by Knott and Curzon (1972), for changes in plasma free and tota
l 
tryptophan concentrations. The findings of Knott and Curzon (1972) were
 disputed, 
however, by Fernstrom et al. (1976), who succeeded in altering cerebral trypt
ophan 
concentrations through dietary manipulation. Specifically, rats were fed e
ither 
carbohydrate and fat (CHO +FAT) or merely carbohydrate (CHO). There
 was no 
difference in brain tryptophan concentrations, even though those rats whic
h ate CHO 
+ FAT had 2 Yi times higher plasma free tryptophan concentrations than rats that ju
st 
ate CHO. The total correlation between brain tryptophan and plasma free
 
tryptophan concentrations (r=0.23) was significantly lower than the correl
ation 
between brain tryptophan and total plasma tryptophan concentrations (r=0
.87). The 
authors therefore concluded that it is the total rather than the free plasma tr
yptophan 
concentration that determines brain tryptophan concentrations. It is furthe
r 
postulated that the L-system carriers may possess a higher affinity for plas
ma 
tryptophan than tryptophan has for albumin and tryptophan is stripped from
 albumin 
as it passes through the cerebral circulation (Fernstrom et al,. 1976; Yuwiler e
t al., 
1977). It would appear from the conflicting literature that both free and to
tal 
tryptophan concentrations influence tryptophan's transport into the brain, a
nd total 
plasma tryptophan can, therefore, influence cerebral serotonin concentratio
ns. 
Summary 
Amino acid transport relies upon the presence of a transport macromolecu
le to effect 
its passage across membranes. Competition between the large neutral ami
no acids 
(LNAA), most notably tryptophan, valine, isoleucine and leucine, affects t
he 
concentration of these amino acids reaching the brain. Certain conditions 
result in a 
decline in BCAA concentrations, thereby increasing the amount of tryptop
han 
entering the brain. The increased cerebral tryptophan concentration leads 
to an 
increased cerebral serotonin production. 
2.1.4 Metabolism of ami.no acids in muscle. 
Upon being taken up into the muscle BCAA's are either used for protein sy
nthesis or 
dearninated to yield branched-chain keto-acids (BCKA) and glutamate. B
CKA's are 
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FIGURE 2.2 The breakdown of amino acids to alanine and the corresponding keto-acids. Alanine ls converted 
into glucose in the liver, and the keto-acids into energy by the tricarboxylic cycle. 
BCAA trans/erase 
BCAA transferase is the enzyme that catalyses the conversion of leucine, isoleucine 
and valine into -ketoisocaproate, -ketomethylvalerate and -ketoisovalerate, 
respectively (Harper et al., 1984). 
THE REGULATION OF BCAA TRANSFERASES 
The rate of transamination is dependent only upon the concentrations of enzyme and 
substrate. Because BCAA transferase has a relatively high km for valine, compared 
to isoleucine and leucine, valine is converted into its BCKA less rapidly than either 
leucine or isoleucine (Pardridge, 1977). Transamination rates may be reduced by a 
build-up of BCKA's, which occurs, for example, during metabolic acidosis where a 
decreased flux ofBCKA from the mitochondria is observed (Block and Buse, 1990). 
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FIGURE 2.3 Regulation of the BCKA dehydrogenase enzyme, by phosphorylation/dephosphorylation 
(Shimomura et al., 1990). 
BC.KA dehydrogenase 
The BCKA's are first oxidatively decarboxylated by BCKA dehydrogenase, a multi-
enzyme complex located on the inner surface of the inner mitochondrial membrane. 
This enzyme complex is similar to the pyruvate dehydrogenase enzyme (Block and 
Buse, 1990), and is the rate-limiting step in BCAA metabolism (Harper et al., 1984; 
Block and Buse, 1990). 
REGULATION 
Like pyruvate dehydrogenase , BCKA dehydrogenase is tightly regulated through a 
reversible phosphorylation (deactivation) - dephosphorylation (activation) 
mechanism, allowing for fine control in enzyme activity (fig 2.3). Activity of the 
enzyme complex is increased during exercise (Shimomura et al., 1990; 
Wagenmakers et al., 1991) and during periods of net protein breakdown, resulting 
from increased glucocorticoid activity (Block and Buse, 1990), and decreased with 
carbohydrate loading prior to exercise (Wagenmakers et al., 1991). 
_ Factors affecting the in vivo activity ofthe_enzyme (see fig 2.3) may include the 
NADH/NAD, acetyl CoA/CoA ratios and keto-acid substrate availability. An 
increase in the NADH/NAD and acetyl CoA/CoA ratios inhibits BC.KA activity by I) 
decreasing activation of the enzyme, and ii) by slowing the active BCKA 
dehydrogenase enzyme (Shimomura et al., 1990). 
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2.1.5 Tryptophan and serotonin metabolism. 
Unlike BCAA's, tryptophan is not metabolised in skeletal muscle, but it does enter 
the brain (Yuwiler et al., 1977). In the brain tryptophan is first hydroxylated to form 
5-hydroxytryptophan, and then decarboxylated to produce 5-hydroxytryptamine or 
serotonin. Tryptophan hydroxylation is unsaturated at physiological levels, the 
reaction rate being controlled by substrate availability (Fernstrom, 1974), and 
therefore any change in the plasma tryptophan concentration will be reflected in the 
cerebral serotonin concentration (Pardridge, 1977). Intravenous injections of 
tryptophan rapidly increase plasma and brain tryptophan concentrations and brain 
serot~nin levels (Segura and Ventura, 1988). 
The principle metabolite of serotonin is 5-hydroxyindoleacetic acid (5-HIAA). This 
breakdown product is formed in a 2 step process involving a deamination by 
monoamine oxidase to yield an aldehyde intermediate, and then an oxidation to 5-
HIAA through the action of aldehyde dehydrogenase. 
Serotonin receptors 
Receptors for serotonin each have their own unique pharmacological, behavioural 
and anatomic profiles (Jacobs and Azmitia, 1992). Serotonin receptors belong to 
three main families, viz. 5-HT 1, 5-HT2 and 5-HT3, and within each a number of 
subgroups exists. 
All three receptor families are present to differing extents in the brain. The 5-HT IA 
receptor is the neuronal cell body autoreceptor and is responsible for some of the 
post-synaptic actions of serotonin, including the descending pain modulating reticulo 
spinal tracts. The 5-HT ID receptor is the axon terminal autoreceptor and is presumed 
to be involved in the inhibition of further release of serotonin from axon terminals. 
The 5-HT2 family is post-synaptic, and is responsible for many of the behavioural 
effects of serotonin release and has been shown to be involved in the action of the 
major hallucinogenic drugs. Finally 5-HT 3 receptors are found in the limbic areas 
where they may be involved in anxiety and psychotic reactions (Jacobs and Azmitia, 
1992). 
The early literature on the post-synaptic effects of serotonin is frequently 
contradictory. Investigators initially expected to find a primary action of serotonin in 
the central nervous system, either excitatory (increasing the activity of postsynaptic 
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target neurones) or inhibitory (decreasing target neuron activity), this however, was 
simplistic and now a more consistent and detailed picture is emerging. 
SEROTONIN'S INHIBITORY ROLE 
Toe primary action of the serotonergic nervous system, particularly in the fore-brain 
is inhibitory, predominately mediated via the 5-HT lA receptor. Serotonin itself may 
also auto inhibit further serotonin release via the 5-HT 1D receptors (Jacobs and 
Azmitia, 1992). 
SEROTONIN'S EXCITATORY ROLE. 
Excitation occurs predominantly in the brainstem and spinal cord. Excitation 
involves mostly motorneuron activation and the effect of serotonin is to amplify the 
responsiveness of target cells to incoming stimuli. Pharmacological analyses have 
identified the 5-HT2 receptors as being responsible for these effects (Jacobs and 
Azmitia, 1992). 
Changes in brain serotonin content 
In humans, alterations in brain serotonin content during exercise cannot be assessed, 
for the following reasons: 
i) Serotonin metabolites in the blood are a poor predictor of brain serotonin 
synthesis as 90% of all serotonin is formed in the gut and, for the same 
reasons, 
ii) Plasma 5-hydroxyindole acetic acid (5-HIAA) concentrations have been 
shown to be an unreliable predictor of brain serotonin turnover (Fernstrom, 
1974), and while cerebrospinal 5-HIAA may be a better predictor of central 
nervous system activity than plasma 5-HIAA, it is not feasible to measure 
CSF levels in an exercise protocol. 
The behavioural and physiological changes resulting from alterations in cerebral 
serotonin turnover, therefore, have to be extrapolated from studies on animals. 
2.2 Plasma amino acid alterations during exercise: 
Physical exercise has a profound effect upon plasma, muscle and liver concentrations 
of amino acids. Following prolonged exercise large amounts of nitrogen are 
excreted, resulting in a negative nitrogen balance, which implies that catabolism of 
protein occurs during exercise. In addition, the participation of amino acids in the 
energetics during exercise is demonstrated through an increased plasma 
concentration of ammonia and urea (MacLean et al., 1991) and in an increased 
concentration of alanine (Brodan et al., 197 6) released by active muscle, following 
the exercise bout. The purpose for this catabolism is at this stage disputed, and the 
various arguments will be discussed. 
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Much attention has focused on the effects of exercise on plasma amino acid 
concentrations (Brodan et al., 1976; Decombaz et al., 1979) and it has been 
speculated how these changes in plasma amino acids might affect various central 
nervous system neurotransmitter levels. Unfortunately these studies are difficult to 
compare as large discrepancies in the effect of exercise on plasma amino acid 
concentrations have been demonstrated. These differences appear to be related to 
intensity and duration of the exercise bout. A summary of the effects of exercise on 
plasma amino acid concentrations in humans can be seen in Table 2.2 (pg. 19). 
Effects of duration & intensity of exercise on plasma amino acid concentrations 
Okamura et al. (1987) investigated the effects of high intensity exercise on plasma 
amino acid concentration in rats. In spite of an increase in the plasma BCAA 
concentration, TRP:BCAA also increased after exercise. 
Following 20 mins. oflow intensity exercise in healthy human subjects both total 
plasma tryptophan and plasma BCAA concentrations decreased producing a 13% 
decrease in the TRP:BCAA ratio. Plasma alanine and glutamine also increased 
significantly over resting values (Brodan et al., 1976 ). Exhaustive high intensity 
exercise in the same subjects produced a significant increase in plasma BCAA 
concentration, while total tryptophan concentrations fell, and the TRP:BCAA ratio 
did not change. Again both alanine and glutamine concentrations increased 
significantly, compared to resting levels. 
Blomstrand et al. (1991) investigated the changes in plasma amino acid · 
concentration during prolonged exercise. In a 30km cross country both the BCAA's 
and total tryptophan concentrations fell significantly, but the TRP:BCAA ratio 
increased as BCAA concentrations fell more than the tryptophan concentration (see 
table 2.2). Similar results were obtained by the same group in two studies, with 
subjects completing 42.2km (Blomstrand et al., 1988;1991) where the TRP:BCAA 
ratio increased significantly. In a similar study Davis et al. (1992) exercised subjects 
at 68% V02 max for over three hours. This produced a large increase in plasma free 
tryptophan, a moderate increase in plasma total tryptophan and no change in BCAA 
concentrations. As a result the TRP:BCAA increased by 9.8%. Similar results are 
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achieved following prolonged exercise in rats (Acworth et al., 1986). In both trained 
and untrained rats the plasma ratio ofTRP:BCAA increased, resulting in an increased 
cerebral tryptophan concentration. 
Ultra-endurance exercise, however, has an even more profound effect on the plasma 
amino acid concentrations. Decombaz and co-workers (1979) found that, following a 
100km competitive run, concentration of most amino acids decreases by between 35 
and 85% of their resting values. The total BCAA concentration fell by 63%, while 
the total amino acid content declined by only 17%. However, as plasma tryptophan 
was not measured it is not possible to calculate the change in the TRP:BCAA ratio. 
These authors also found that the urinary excretion of all amino acids was lowered 
after the race, mediated through a reduced renal clearance. 
The decline of the plasma BCAA concentration is possibly linked to the fact that the 
activity of the BCKA dehydrogenase enzyme is enhanced during exercise (Hood and 
Terjung, 1987; Shimomura et al., 1990). This increase in the BCKA dehydrogenase 
activity has prompted some investigators to suggest that BCAA's might contribute 
significantly to the energy demands of the organism during periods of starvation or 
endurance exercise (Dohm et al., 1977) (see section 2.21). 
Inconsistencies in the changes of plasma BCAA 'sfollowing exercise 
Despite the evidence demonstrating the decrease in plasma BCAA concentrations 
during exercise, there are data which disagree. For example, Dohm et al.(1981) 
showed, in rat experiments, that plasma BCAA concentrations following exhaustive 
exercise ( either swimming or running) increases. In addition, Hagg et al. (1982) 
showed that two hours of mild leg exercise in human subjects, failed to produce a 
change in the plasma BCAA concentrations. The authors explain this by the fact that 
protein degradation increased and the utilisation of leucine for protein synthesis 
decreased markedly. They also suggested that these processes occurred at a rate 
greater than amino acid utilisation, which resulted in an unchanged plasma amino 
acid concentration (Hagg et al. 1982). However, the reasons for these discrepancies 
are unclear, but they may result from a combination of the following: 
• EXERCISE PROTOCOL 
It is important to consider the type of exercise involved when making conclusions 
about the effect of exercise on plasma amino acid concentrations, as plasma BCAA 
oxidation appears to be linked to the intensity of the exercise. For example, 
exhaustive exercise at 75% ofV02 max, for 1 Yz to 2 hours, in six healthy, young 
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men failed to decrease the BCAA levels (MacLean et al., 1991), whereas BCAA 
concentration decreased by 63%, following a 100km run at approximately 60% V02 
max (Decombaz et al., 1979). 
• TRAINING 
Training, too seems to play a role in the plasma concentrations of amino acids, and 
their oxidation during exercise. Einspahr and Tharp (1989) investigated the amino 
acid responses of a highly trained group and a sedentary control group of humans, 
following a bout of intense exercise. The trained group had higher plasma 
isoleucine, leucine and tyrosine concentrations at rest, and their plasma alanine 
concentrations post-exercise were significantly higher those that of the sedentary 
control group. 
Henderson et al. (1985) investigated the training effects on leucine oxidation in rats, 
using constant leucine infusion. Leucine oxidation was 40% higher in the trained 
group during both exercise and rest. The results show that whole body leucine 
turnover is increased by training and that leucine oxidation is increased by both 
training and a single bout of exercise. 
Effect of exercise on serum tryptophan concentrations 
The influence of exercise on plasma tryptophan concentrations is less clear-cut. This 
is because exercise impacts differently on free and bound tryptophan. Plasma free 
tryptophan increases during prolonged exercise, as a result of the increased plasma 
FFA concentration, which displaces tryptophan bound to albumin (Fernstrom and 
Wurtman,1974a). 
Exercise (running for 1-2 h at 20 m/rnin) causes time-dependent increases in the 
plasma free tryptophan concentrations and brain tryptophan concentrations in the rat, 
and this may lead to an increased metabolism of cerebral serotonin, as suggested by 
elevated levels of 5-HlAA (Chaouloff et al., 1985). 
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Effect of exercise on plasma serotonin concentrations 
One of the first studies to demonstrate an increase in cerebral serotonin following 
both acute and chronic exercise, in rats, was conducted in the early '70's (Barchas and 
Freedman, 1973). More recently other investigators have also demonstrated that 
brain serotonin content increases following endurance exercise in the rat (Brown et 
al., 1979; Chaouloff et al., 1985; Acworth et al. 1986). These authors measured both. 
plasma and cerebral tryptophan concentrations, and found a positive relationship 
between brain and plasma tryptophan concentrations. They suggested that plasma 
tryptophan concentration may serve as an indicator of brain tryptophan 
concentration. 
In humans, the possibility that increases in the concentration of tryptophan in the 
brain will elevate the level of brain serotonin has to be assumed (Fernstrom & 
Wurtman, 1971). Support for that assumption comes from the work ofWurtman 
(1983) that showed that a single dose ingestion of 500mg oftryptophan, in a group of 
healthy young men, produced a significant increase in their self-reported 
fatigue/inertia and a decrease in their vigour/activity rating, as measured by the 
POMS (Profile Of Mood States) test. 
USE OF DRUGS TO MODIFY BRAIN SEROTONIN CONTENT 
A number of studies have used drugs to investigate the potential influence of raised 
cerebral serotonin content on exercise performance. Bailey et al. (1992) investigated 
the influence of a serotonin agonist on exercise performance. An injection of m-
TABLE 2.2 Effects of exercise on plasma amino acid concentrations in humans. 
Exercise Intensity* Duration Total Free BCAA TRP: Reference 
(hours) TRP TRP (% L\) BCAA 
(% £1) (% L\) 
Incremental High Fatigue -13 NM 9 -2 Brodan et al. 
1976 
lOOKm Medium NM NM -63 Decombaz 
eta!. 1979 
30Km Medium <2.83 -15 NM -39 17 Blomstrand 
et al. 1991 
42.2Km Medium <3.5 -6 NM -23 13 Blomstrand 
et al. 1991 
42.2Km Medium <4.7 4 59.5 -24 20 Blomstrand 
- et al. 1988 
68% V02 Medium 3.15 14 86.4 -4 10 Davis et al. 1992 
max 
1.5 W/Kg Low 0.33 -18 NM -8 -13 Brodan et al. 
1976 
NM = not measured 
* Subjective rating of the exercise intensity of each study. 
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chlorophenyl piperazine (m-CPP), which produces an increased serotonergic activity, 
resulted in a decreased endurance exercise performance, in treadmill trained rats 
(Bailey et al., 1992). It is not known, however, what effect m-CPP might have had 
on metabolic and cardiovascular processes in the periphery, and these effects may 
have overridden any effects of serotonin acting on the central nervous system. 
The adverse effect of an increased serotonergic activity on exercise tolerance has also 
been demonstrated in humans (Wilson and Maughan, 1992). In this study the 
authors exercised recreational athletes to exhaustion on a cycle ergometer at 70% of 
V02 max, after administering paroxetine (20mg), a serotonin uptake inhibitor. 
Following the paroxetine administration endurance was decreased from 116 ruins. to 
94 mins. (p~0.05). The fact that these were recreational athletes, however, is relevant 
as it has been shown that the state of training is an important modulator of BCAA 
oxidation (Einspahr and Tharp, 1989; Henderson et al., 1985). 
THE EFFECT OF TRAINING ON BRAIN SEROTONIN CONCENTRATIONS 
The effect of endurance training on the brain serotonin content in rats was 
investigated by Brown et al. (1979). Rats ran on a treadmill were exercised for 30 
mins., 5 days/wk for eight weeks. In most areas of the brain cerebral serotonin 
content increased in the exercise trained group compared to the sedentary group. The 
authors speculated that an adaptation to training leads to an increased cerebral level 
of serotonin, and this serves as a neurotransmittal link to increased incorporation of 
amino acid within muscle, as well as decreased appetite drive and sensitivity to pain. 
2.2.1 BCAA skeletal muscle oxidation. 
BCAA's are the only amino acids to be oxidised by skeletal muscle and other 
peripheral tissues (Newsholme and Leech, 1984). Uptake ofBCAA by skeletal 
muscle occurs via two pathways; uptake for oxidation is sodium independent while 
uptake for incorporation into muscle protein is sodium dependent. Although BCAA 
oxidation in the liver occurs at a rate faster than that of muscle, the muscle remains 
the major site ofBCAA degrada!ion due to its large mass (Harper et al., 1984). The 
rate of leucine oxidation in muscle is limited by its rate of transport from the 
intracellular pool. 
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Ex.ercise induced changes in oxidation of BCAA 
Many studies have outlined the nature of the oxidation of leucine in skeletal muscle 
in both rats and humans. The majority of these studies have been performed in 
exercising subjects . . 
During mild exercise (30% ofV02 max) Wolfe and co-workers (1982) demonstrated. 
that human whole body leucine oxidation increased by 150%, from resting values. 
These results were duplicated more recently where exercise at 45% V02 max 
increased leucine oxidation by 160%, from 20 ± 5 mol/kg/h at rest to 52 ± 17 
mol/kg/h during exercise (Knapik et al., 1991). Leucine oxidation, at rest, in these 
subjects was further enhanced by a 3Y2 day fast. White and Brooks (1981) have 
shown that in rats the rate of leucine oxidation is low at rest and this increases in 
proportion to the metabolic rate (V02). In addition, Dohm and co-workers (1977), 
have demonstrated that the 14C02 production in trained, compared to untrained rats, 
increases significantly after [14C]-leucine injection. Moreover, the enzymes involved 
in leucine oxidation, in the muscle adapt to endurance training similarly to the 
enzymes involved in carbohydrate and fat catabolism. 
Finally, BCAA oxidation has been shown to increase following an elevation of 
plasma free fatty acid concentration, and decreases in response to increased plasma 
glucose concentrations (Odessey and Goldberg, 1972). This is therefore especially 
important during exercise where the plasma FF A increases and plasma glucose 
concentrations decrease. 
Teleology for BCAA oxidation 
The rationale for skeletal muscle BCAA oxidation remains a subject of much debate. 
Although it is generally accepted that carbohydrates - and to a lesser extent fats - are 
the primary source of energy during exercise. Protein catabolism has, however, been 
proposed as an important source of energy, especially in the absence of other fuels. 
Brooks (1987) has stated that amino acids when oxidised by muscle can contribute 
significantly to the energy production during prolonged exercise, and this permits the 
maint~nance of high muscular power outputs. Other authors have shown that 
·-
between 5 and 10% of the fuel for prolonged exercise may be derived from amino 
acids (White and Brooks, 1981; Lemon and Mullin, 1980). Dohm and colleagues 
(1977) however, have calculated that 8.4 kJ of energy could have been derived from 
protein catabolism, in the trained rat. This amounted to 3 7% of the calculated energy 
expenditure during an exercise bout. Amino acids may also play important 
anapleurotic functions in sustaining the whole metabolic apparatus during exercise 
and recovery. 
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Results from a number of studies on protein dynamics during starvation may provide 
important clues on the nature of amino acid oxidation during exercise. Adibi et al. 
(1975;) stated, for example, that increased transamination together with the 
stimulated oxidation, enhances the ability of skeletal muscles to utilise BCAA's as a 
metabolic fuel during periods of caloric deficiency. · In other words it is conceivable 
that amino acids may play an important role in the provision of energy during 
prolonged endurance exercise when the availability of alternative energy sources 
becomes low. 
There are other possible explanations for the observed increase in amino acid 
oxidation during exercise. Felig and Wahren (1971), for example, noticed that large 
amounts of alanine are released from skeletal muscle following the uptake of 
BCAA's. They proposed a glucose-alanine cycle , whereby gluconeogenic substrate 
was shuttled to the liver. This theory proposes that when amino acids are oxidised, 
muscle 
pyruvate - produced from glucose via glycolysis - is transaminated into alanine. 
Alanine is released from the muscle and is transported to the liver. Alanine release is 
the rate-limiting step for glucose production in starved humans (Felig et al., 1970). 
Goldstein and Newsholme (1976) modified the proposed cycle somewhat, suggesting 
that both the carbon skeleton and amino groups are supplied by glutamate, the amino 
acid produced from a transaminase reaction .CFig 2.4). In the muscle, BCAA's are 
converted by an amino acid transaminase into a BCKA. The product is then 
converted into oxaloacetate, in the tricarboxylic acid cycle. Oxaloacetate is then 
converted into phosphoenolpyruvate (PEP) by phosphoenolpyruvate carboxylase, 
which is converted into pyruvate. Pyruvate is then transaminated into alanine, 
receiving the amino group from glutamate. 
According to these authors this metabolic scheme explains how certain amino acids 
are oxidised by muscle. So, in the absence of glucose, certain amino acids are 
converted into alanine in muscle. This alanine, in addition to its role as a 
gluconeogenic substrate, may provide an alternative for the removal of nitrogen from 
the muscle so preventing an exercise induced hyperammonemia. This occurs in the 
conversion of glutamate to a-ketogluterate with the production of alanine. The 
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nitrogen is transferred from the glutamate to pyruvate, which is converted into 
alanine, and in this way a nitrogen molecule is removed from the muscle. 
Goldstein and Newsholme's alternative scheme has been met with widespread 
approval as many researchers believe that amino acid contribution to energy 
production is low and this therefore better explains the rationale for amino acid 
oxidation (Hood and Terjung, 1987; Poortmans et al., 1991). 
Hood and Terjung (1987), for example, maintain that convincing data on the 
contribution of BCAA's to overall energy requirements are lacking and that the best 
estimates are that less than 5% of the energy needs of the muscle could be met by 
leucine oxidation under physiological conditions. Because exercise intensity and 
duration differed in these trials it is difficult to compare studies and more work is 
required to elucidate the role of protein as ·an energy source during exercise. 
BCAA a-Ketogluterate Alanine 
BCKA Glutamate · Puruvate 
~ Oxaloacetate / ----~ PEP 
MUSCLE FIBRE BLOOD 
FIGURE 2.4 A revised scheme for gluconeogenesis, according to Goldstein and Newsholme (p556, 1976). Here both 
the carbon skeleton and the amino group are derived from the deamination of an amino acid 
Poortmans et al. (1991) also dispute the claim that proteins are oxidised for energy, 
and they suggest a more subtle role for the oxidation of branched-chain amino acids. 
These authors maintain that an increased BCAA uptake by the muscle may explain 
the decreased plasma BCAA level following endurance exercise. Because plasma 
total tryptophan concentrations did not change, an increased quantity of tryptophan is 
transported across the blood-brain barrier. This cerebral tryptophan is then converted 
into serotonin. 
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In light of the above it does seem reasonable to suggest that the oxidation of amino 
acids occurs to provide a communications link between the muscle and the brain, and 
this then has important consequences for feeding behaviour and in the sleep-arousal 
cycle. · 1t seems unlikely, however, that the sole reason for the oxidation of amino 
acids is to alter brain serotonin concentration during long periods of physical activity. 
Rather, it is more likely that in vivo, neurotransmitter production and 
gluconeogenesis are the primary objective ofBCAA oxidation and energy production 
is probably an important by-product during periods of substrate insufficiency (for 
example, exercise and starvation). 
2.3 Summary of studies addressing the thesis hypothesis: 
Many studies have attempted to investigate the effect of BCAA supplementation on 
exercise performance in both rats and humans. These studies have either altered 
cerebral serotonin indirectly through nutritional intervention, or they have altered 
brain serotonin pharmacologically. The results and conclusions of these studies will 
be discussed. 
Indirect intervention. 
The influence of BCAA supplementation on exercise performance, has been tested 
on human subjects in the field (Blomstrand et al., 1991). Subjects received either a 
BCAA supplement or a placebo drink throughout a standard marathon ( 42.2km) road 
race. There was no significant difference between the performance times, until the 
authors arbitrarily subdivided the groups into fast and slow runners. Running 
performance in the marathon was improved for slower runners (3:05 - 3:30 hours) 
when BCAA's were ingested during the race, but there were no significant effects in 
the faster runners (<3:05 hours). An assessment of mental fatigue was measured by 
the Stroop colour word test (Stroop 1935). Mental performance improved post 
exercise, in the BCAA supplemented group only. R~sults from this study indicate 
that both mental and physical performance, in slower runners, improved after 
ingestion of a BCAA supplement. 
A number of questions still remain, however, as this investigation was not properly 
controlled. As it was a field study a number of external variables may have 
influenced the results. Motivation, for example, would most definitely have differed 
between athletes, the study design, in spite of using large sample sizes (n=193), used 
a single cross-over method in which each athlete was tested on one occasion only. 
The post-exercise evaluation was completed only 1-2 hours after completion of the 
race, during which time many of the changes may have been reversed. Division into 
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fast and slow runners, too, is contentious, as there does not appear to be any basis to 
the method of division. Likewise, conclusions from these experiments may be 
confused by any peripheral effects that these nutritional interventions may have had 
(Wagenmakers et al., 1991). 
A recent well controlled study by Davis et al. (1992) investigated the effects of 
carbohydrate drinks on the oxidation of plasma BCAA's and on plasma free 
tryptophan, in humans. Plasma concentration of the BCAA's, following the ingestion 
of a carbohydrate drink, were decreased compared to those following the placebo, 
and there was an increase in TRP:BCAA. Davis et al (1992) suggest that the 
combination of carbohydrate and BCAA's increase skeletal muscle uptake of the 
amino acids due to an increased insulin concentration. In this study the cyclists 
receiving carbohydrate exercised for a significantly longer period than those 
receiving the placebo. However, there was no statistical difference in blood glucose 
levels, indicating that plasma glucose was not the factor limiting exercise 
performance. The authors conclude that central fatigue may have influenced cycling 
performance, but no measure of central fatigue was made in these athletes. 
Pharmacological alteration of brain serotonin 
Exercise performance in rats was investigated after the administration of m-
chlorophenyl piperazine (mCPP), a serotonin agonist. Rats received either a placebo 
or varying concentrations of mCPP (Bailey et al., 1992). At the greatest 
concentration of the drug, which increased brain serotonin concentration the most, 
the rats run time to exhaustion on the treadmill was significantly decreased. The 
authors conclude that these results provide evidence that increased brain serotonin 
results in a reduction in endurance performance. However, the other effects of mCPP 
on exercise tolerance are not known, and it is likely that this drug adversely affects 
motor function (Wilson and Maughan, 1992). In a subsequent study Bailey et al. 
(1993), again demonstrated a decreased run-time to exhaustion, in rats, following 
administration of quipazine dimaleate, a serotonin agonist. In addition they showed 
an improved exercise tolerance following the administration of a serotonin 
antagonist. They have demonstrated that pharmacological interventions produce 
changes in the performance of ~xercising rats. However, it is still not known what 
effects these drugs may have had on the peripheral musculature, and this obscures 
their results. 
Wilson and Maughan (1992) used a serotonin re-uptake inhibitor (paroxetine) to 
investigate the effects of an increased serotonergic activity on exercise performance 
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in humans. These authors exercised seven recreational cyclists (age= 43 ± 6 years), 
at 70% V02 max, until exhaustion, and time to fatigue was significantly less after 
ingestion of paroxetine. Toe authors also measured metabolic and cardiorespiratory 
variables, none of which were different between the two trials. Toe authors interpret 
this to indicate that it is unlikely that the difference in exercise performance is 
mediated by peripheral effects, secondary to an altered activity of central serotonin 
pathways. This study, too, does not completely resolve all the questions, as it is not 
applicable to competitive athletes, for the following reasons: Subjects were 
recreational cyclists, and the effect of serotonin on performance is different 
depending on whether subjects are trained or not (Blomstrand et al., 1991). Toe level 
of training also affects the accumulation of cerebral serotonin. In addition, it is not 
known what effect paroxetine might have on muscle function. 
2.4 Mental Fatigue: 
Introduction 
Fatigue occurs either peripherally or centrally (see Fig 1.1) As most of the research 
effort to date on fatigue after prolonged, submaximal exercise has been directed at 
the periphery, very little is known about central fatigue, and few testable hypotheses 
exist. One hypothesis is that an increased serotonin concentration may influence an 
athlete's concentration and may lead to an increased perception of fatigue 
(Blomstrand et al., 1988). Mental overload occurs when a person is required to 
perform beyond the limits of his or her resources. Toe scope and importance of 
fatigue during work or exercise is vast as it has implications for reasons of safety, 
efficiency and health. This type of fatigue may also be important in those sports 
requiring a great deal of concentration, for example, motor racing or even cycling. 
No single test exists for the purpose of measuring mental fatigue, and the reaction-
time paradigm as described by Sternberg (1966) was used in the present study as it is 
an appropriate test to monitor acute changes in cognitive function (Hosstetler, 
personal communication). This test was selected over the Stroop Colour and Word 
Test as it has a very low error rate, there is no learning effect following repeated 
exposure , it uses letters which are familiar and discriminable (Sternberg; 1966) and 
each test takes only 2Y2 minutes, compared to the 15 minutes of the Stroop CWT 
(Newsholme et al.,1991). It is important to do the test immediately following the 
exercise bout as changes in mental performance are slight, and are likely to return to 
resting levels rapidly once the exercise has been completed. 
27 
Quantification of mental fatigue 
Newsholme and co-workers (1991) were the first to document the anecdotal report 
that athlete's felt more aware and alert following the ingestion of BCAA's during 
prolonged exercise. They used the Stroop colour and word test (CWT) to quantify 
this subjective observation. According to the authors the Stroop CWT was chosen as 
it provides a useful tool in the study of neurophysiological and cognitive processes. 
Following a 30km cross-country race, performance on the Stroop test improved in 
most subjects consuming a BCAA drink. This preliminary data indicates that BCAA 
administration may help to offset mental fatigue, that is, if levels of plasma BCAA's . 
can be maintained at resting values, a drop in the level of concentration might be 
prevented during prolonged endurance exercise (Blomstrand et al., 1991). 
2.5 Summary of the Literature: 
From the above discussion it can be seen that several studies show that plasma 
BCAA concentrations decrease during prolonged exercise. Those studies that 
dispute this finding followed exercise protocols which were shorter and more intense. 
The literature concerning the change in tryptophan during prolonged exercise is less 
clear, as total plasma tryptophan does not always increase. However, it is clear that 
free tryptophan does indeed rise, following the increase in plasma FF A during 
prolonged exercise. This results in an increase in TRP:BCAA (Table 2.2), producing 
an increase in cerebral serotonin concentrations. Human cerebral serotonin 
concentrations cannot be measured, and its metabolites do not provide an accurate 
estimate of changes in the brain, however, data from rat studies indicate that 
alterations in plasma tryptophan concentrations, or an increased TRP:BCAA, result 
in an increased cerebral tryptophan which leads to an increased serotonin 
concentration in the brain. 
Although there is no direct evidence that an increased cerebral serotonin content 
causes an increase in the amount of amine released into the synapses, it can be 
assumed that "since an increased amount of neurotransmitter will probably be 
released whenever the neurones that store serotonin are excited, it appears likely that 
brain function will be modified" (Fernstrom and Wurtman, 1974a, pg. 84). Changes 
in physiology and behaviour may also be indicative of alterations in brain serotonin 
release. Wurtman (1983) for example, found that a single dose ingestion of 
tryptophan in a group of healthy young men caused a significant increase in their 
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self-reported fatigue/inertia and a significant decrease in their vigour/activity ratings 
according to the POMS (Profile Of Mood States) test. Although it appears that an 
increased plasma TRP:BCAA is causally linked to a decline in mental and physical 
performance, after prolonged exercise, this theory has not been tested adequately in a 
well controlled laboratory experiment. 
2.6 Scope of this thesis. 
The first aim of the study was to develop an exercise protocol, in humans, where 
serum BCAA concentrations decreased, as a result of the prolonged exercise bout, 
causing an increased TRP:BCAA. The second aim was to prevent the increase in 
TRP:BCAA by having the subjects ingest a BCAA supplement during exercise. 
Physical and mental performance, and various cardiorespiratory and haematological 
variables were measured. This model was then used to examine the thesis 
hypothesis. 
Before embarking on the study a method to analyse the plasma amino acid 
concentration had to be devised. The HPLC was selected as this device allows for 
the rapid and sensitive determination of plasma amino acids (Turnell and Cooper, 
1982). An important part of this project was therefore to develop the HPLC system 
to validate its ability to accurately measure amino acid concentrations. 
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Chapter 3 - High performance liquid chromatography: 
Method development and troubleshooting 
3.1 Introduction: 
At the outset of this investigation it was decided that one of the preliminary tasks 
would be the development of an application to analyse serum amino acids using high 
performance liquid chromatography (HPLC). HPLC was a technique new to this 
laboratory, and a large amount of time was therefore required to validate both the 
quantification and qualification of the method. 
3.2 Chromatography. 
Chromatography is the separation of a chemical mixture into its individual 
components. The term encompasses a number of different applications and can be 
used to separate, isolate and quantify most substances, measure molecular weight of 
polymers and to characterise different aspects of the structure of substances. 
3.3 High performance liquid chromatography. 
High performance liquid chromatography, which has been in use since the 1960's, is 
now the most powerful and widely used chromatographic technique. It is largely 
utilised by research institutions and the pharmaceutical industry to analyse proteins, 
peptides, amino acids, sugars, nucleotides, catecholamines, vitamins, drugs and 
toxins. In the last 15 years particularly, much has been learned about the basis of 
HPLC separations and how they can be improved by varying experimental 
conditions. 
Advantages of HPLC 
For many years gas chromatography (GC) was the method of choice for analysis of 
unknown samples. HPLC has, however, superseded GC as the method of choice for 
the analysis of many compounds. This is as a result of the increased accuracy and 
precision of high performance liquid chromatography, which displays coefficients of 
variation of 0.1 to 0.5%. In addition a large number of different applications are 
possible, HPLC's are relatively simple to operate ( once method development is 
complete), sample preparation is simple and analysis is rapid. Finally, HPLC is 
extremely sensitive and can achieve good quantification and qualification in the 
femtomole c10-15) range, as long as sample preparation and degassing is suitably 
performed. 
Disadvantages of HPLC 
The major disadvantage of using HPLC is that, in spite of the simplicity of the 
operational basics, method development and troubleshooting are demanding and 
time-consuming. 
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For an HPLC run the sample is prepared by removing the matrix, (a collection of 
interfering compounds), and dissolving it in a liquid solvent. This sample is then 
introduced to a column under high pressure. Components are separated into discrete 
bands following interactions with the mobile and stationary phases. The stationary 
phase consists of an immobile packing material within the column, while the mobile 
phase comprises a liquid solvent containing the sample. Depending on the 
application, one (isocratic system) or more (gradient system) different solvents may 
be required to effect an optimal separation. 
3.4 Chromatographic Theory: 
The crucial element of an HPLC application is the separation process. This occurs in 
a column, a narrow bore (0.46mm) stainless steel tube, varying in length, typically 
from 7 to 30cm, packed with small (3-10mm) silica particles. The silica is coated 
with a particular substances to affect a specific separation. As the sample moves 
through the column the components interact differently with the stationary phase. 
This results in component bands traveling down the column at different velocities. 
The aim of a chromatographic separation is to achieve good retention and therefore 
good resolution between eluting component bands, as well as reducing band 
spreading (fronting and tailing) of peaks. This is achieved through the manipulation 
of many parameters. 
Resolution. 
As components proceed at different velocities throu~h a column they separate and 
begin to broaden. An optimal separation will seek to separate each component 
sufficiently within a reasonable time. Resolution of a peak is a combination of both 




Selectivity is the ability of a certain set of experimental conditions to discr
iminate 
between two compounds. Selectivity can be optimised through alterations
 in column 
type (C8 to C18) and/or mobile phase (polarity, pH and temperature). 
COLUMN EFFICIENCY 
This may be defined as the ability of a particular column to prevent the sp
reading of 
a component of interest in the chromatogram. Efficiency can be enhanced
 by 
increasing column length and optimising the flow rate through the column
. 
3.5 Validation & Calibration: 
The validation of any HPLC application is ail important part of technique 
development. Because the system is extremely sensitive, small changes, c
an result in 
large variations in chromatographic output. Validation of the application u
sed in this 
study revealed it to be accurate, precise, specific and reproducible. The ap
plication 
was validated using standard additives. Twenty microliters of a pure singl
e standard 
was added to the standard cocktail and then to the sample matrix. The co
cktail 
consisted of 500µ1 of each of the 17 amino acid standards, dissolved in lL
 of double-
distilled, deionised water. The sample matrix consisted of a precipitated b
lood 
sample, treated in the same manner (for details see section 4.27). Results 
between 
the spiked and unspiked chromatograms were then compared and analysed
 in terms 
of percent recovery. Precision of each chromatographic run was checked p
rior to 
each series of analyses, which consisted of IO runs, during the calibration 
of the 
machine. 
In the present study calibration was performed every morning on start-up, and t
hen 
following every ten samples, by completing two chromatographic runs of 
the 
standard 'cocktail' solution. The coefficient of variation between runs and
 drift over 
time was calculated. If the coefficient of variation between calibration run
s was 
greater than 3% another calibration was performed, ensuring a high degree
 of 
accuracy for calculation of unknown amino acid concentrations. Drift was
 
determined by calculating the ratio between the internal standard (Methio
nine 
sulfone ) and the leucine peak, and then comparing these ratios between ca
librations. 
Toe average value of the ratio was 21.46% ± 1.98%. Again the difference was
 no 
greater than 3 %. The method proved to be reproducible in that it showed les
s than 
5% day-to-day variation. 
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FIGURE 3.1 An HPLC trace of the standard amino acid 'cocktail' solution, used for 
calibration of the machine (for abbreviations see Table 4.1). 
An internal standard was used to correct any small differences between runs. An 
internal standard is often preferred in HPLC as it reduces errors resulting from 
sample preparation, injection bias and technique. With internal standardisation a 
known amount of substance is added to both the standard and the unknown solutions. 
The quantification of all peaks is then related to the concentration of the internal 
standard. 
The choice of an internal standard is an important one, and it must satisfy the 
following criteria: 
i) it must be completely resolved from all peaks, 
ii) should elute near the middle of the chromatogram, 
iii) must be similar in concentration to the peaks of interest, 
iv) should not react with any of the sample components, and 
v) it must be pure and not appear naturally in the sample. 
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Because calibrations runs are time consuming it is important to determine an optimal 
interval for recalibration. In this study calibration was performed every ten samples 
as this represented a balance between time constraints without compromising 
accuracy or precision. 
Other important considerations that had to be taken into account to maximise the 
reproducibility of the technique included the following: 
ST ABILITY OF THE ANAL ITE. 
Decomposition of the samples over a period oftime in the sample and/or standard 
will result in an underestimation of the amount of component present. Derivitisation 
of a sample includes the processes undertaken to render the components of interest 
visible to the detector attached to the HPLC. In the application used in this study, for 
example, o-pthaldialdehyde (OP A) was added to the plasma containing the amino 
acids. The OPA combines with the NH2 group on each amino acid and renders it 
fluorescent. Any differences in component concentration over time suggests 
decomposition. Stability of the analyte was assessed by changing the length of time 
between derivitisation of the sample and between injection onto the column. The 
analyte did prove to be unstable with a decrease in fluorescence being observed over 
time. This is consistent with data of Cooper et al. (1984). In order to account for 
this a standardised time of one minute, between derivitisation and injection, was used 
to reduce variability. 
STANDARD PURITY 
Pure samples are crucial to ensure accurate quantification of the unknown. Standard 
solutions were constituted with double-distilled deionised water and high quality 
standards (Sigma Chemical Company, St. Louis, MO 63178). Standard solutions 
were made up to a large volume, divided into aliquots and then stored until required. 
Further it is possible that detector output can become non-linear in the upper range of 
solute concentration, and therefore the linearity of the analysis, within appropriate 
limits, was confirmed by injecting a series of standards varying from 50 to 150 
percent of the expected working assay range. A regression line through the standard 
curve was not significantly different from zero (r = 0.89). 
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3.6 Problems encountered during method development: 
The following is a brief synopsis of the problems encountered and how these were 
overcome. Both troubleshooting and method development are crucial skills required 
by a chromatographer, and much of the progress is made through trial and error. 
Errors in the application may arise from a number of possibilities and may initially 
be difficult to pinpoint. However, with increased exposure to HPLC confidence and 
problem solving becomes easier and more rapid. Effective troubleshooting requires 
that only one variable is changed for a particular run so making the alteration 
unambiguous. This makes troubleshooting a time consuming process and method 
development often takes months or even years. 
In attempting to solve a problem it is first necessary to identify the type of problem, 
and these typically include one of the following: 
i) Leaks 
ii) Pressure 
iii) Quantitation or data quality 
iv) Hardware, and 
v) Chromatogram. 
The following is a brief description of the problems encountered during method 
development in this study. 
The standard solution was originally made up of the ten essential amino acids, as 
these were considered to be 
most important for this study. 
These were constituted 
singly, so that each amino 
acid's retention time could be 
calculated in the given 
application. At this point 
only the ten dietary essential 
amino acids were used, and 
the technique was refined for 
these. Each amino acid was 
injected singularly, in three 
TABLE 3 .1. Differences in (Rt) and area or the BCAA 's 
in successive chromatographic analyses (9th Sept. 1991). 
Amino Run# Rt Peak Area 
Acid (mins.) 
Valine 1 12.91 106298 
2 12.20 99970 
3 12.29 185659 
Isoleucine 1 14.20 81361 
2 14.19 44006 
3 14.10 48180 
Leucine 1 14.92 ·- 135646 
2 14.90 128941 
3 14.94 167216 
Rt = Retention Time; Peak Area in arbitrary units 
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successive runs, and the resultant retention times (Rt) and peak areas were compared 
(Table 3.1). What was immediately obvious is that there was an unacceptable 
difference in both retention times and peak areas between runs. 
The changes in retention time (Rt) may be due to a contribution of many factors 
(Table 3.2). During method development these all influenced the separation, 
preventing unambiguous peak identification. 
PROBLEMS RELATED TO MOBILE PHASE AND REAGENTS 
The appropriate choice of solvents is an important variable in effecting a good 
separation. Because sample components interact to different degrees with the 
stationary phase of the column the solvent must be sufficiently strong to remove well 
retained components but weak enough not to cause simultaneous removal of poorly 
retained compounds. 
GRADIENT 
Resolution was improved 
through the use of a 
gradient system. Here, 
by altering the 
contribution of two 
different mobile phases, 
TABLE 3 .2. Effect of change in separation conditions on sample 
retention iri reversed-phase HPLC (modified.from Dolan and Snyder, 
1989). 
Variable /J.. in Variable Average /J.. in Rt 
Flow Rate +1% -1% 
Temperature +1°C -(1-2%) 
Mobile Phase Composition 
Organic +1%v -(5-10%) 
Solvent 
pH +0.01 unit ±(0-1 %) 
having different strengths, throughout the run an optimal separation was achieved. 
Gradient elution is typically used in complex separations containing a number of 
particles having different characteristics (e.g. plasma amino acids). In this reversed-
phase HPLC separation a polar (large water content) solvent was introduced at 100% 
and then the concentration of the non polar solvent (methanol or acetonitrile) was 
gradually increased to a point which results in complete elution of the components of 
interest. A large amount of time was spent optimising the gradient which is shown in 
Fig 4.1, pg. 54. 
CONSTITUrION 
In the preparation of a mobile phase the components should be measured individually 
and then combined, as the added volumes of two different liquids does not equal the 
sum of their individual volumes. Differences in mobile phase make-up will result in 
changes in pH and volume, leading to changes in retention times. After constitution 
mobile phases should be degassed. Air in the solvent may result in valve failure or in 
flow rate or pressure inequalities. Filtration and degassing can be achieved 
simultaneously by attaching a specialized filtration flask to a vacuum pump. 
Solvents should be filtered through pores no larger than 0.45µm. 
CONTAMINATION 
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Unless extreme care is taken mobile phase contamination will occur. Even extremely· 
small changes in sample purity can result in large retention time differences between 
successive separations (Table 3.2). Mobile phase contamination occurs when errors 
are made in the manual preparation of solvents or if there are changes in the 
composition of the solvents (e.g. selective evaporation of a solvent or CO2 uptake 
leading to changes in pH), which may occur overnight. In an effort to limit 
contamination glassware was washed in distilled water, mobile phases were 
constituted identically, sealed with parafilm, and solvents were stored at 4°C. This 
reduced the retention error significantly and resolved much of the error seen in Table 
3 .1. Additional variation between runs may have been due to changes in the 
composition of the derivatising agent, OPA. This reagent was later ordered already 
constituted from Sigma Chemical Company (Sigma Chemical Company., St. Louis, 
MO 63178). 
ALTERATION IN PH 
The pH of the mobile phase is crucial as a change of only 0.1 units may effect a 
change of 10% in retention time (Table 3.2). pH should always be measured in the 
aqueous phase only and then the organic modifier ( e.g. acetonitrile) should be added. 
A method will usually specify the degree to which pH may vary, depending on the 
methods inherent sensitivity to pH. However, as a general rule pH should not deviate 
by more that 0.1 units between successive batches of mobile phase. Buffers are often 
used to stabilize the pH of the solution, but these can produce a number of problems 
related to the smooth operation of the equipment. When using buffers extreme care 
must be taken that it remains soluble in the organic modifier. This is especially true 
of gradient systems where the percentage of the organic modifier increases 
throughout the run. Often a buffer may precipitate out in very high concentrations of 
organic modifier and this blocks the stainless steel tubing, valves, injection ports and 
column fiits. 
EQUILIBRATION 
Substantial changes in retention time between two successive chromatograms can 
result from incomplete equilibration. After running a gradient program the column 
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requires some time to re-equilibrate. Snyder et al. (1988) suggest that 10 to 20 
column-volumes is usually sufficient to equilibrate a reversed-phase column. For a 
10cm x 0.46 mm column, therefore, 10 to 20 ml of mobile phase A was required for 
equilibration. At a flow rate of 1.3 ml/min equilibration would talce approximately 
15 minutes. The time between successive injections.was standardised (5-10 
minutes), so that samples were introduced onto a column containing identical 
proportions of the mobile phases. Once an equilibration time was included in the 
method, ensuring column equilibration prior to each run (see Fig. 4.1, pg. 54) 
repeatability was further improved. 
LEAKS AND FLOW RATE DISCREPANCIES 
Changes in both flow rate and leaks are related. Because operating pressures are 
extremely high ±3000 psi leaks are likely to occur at any weaknesses, e.g. joints. 
Leaks may also occur where seals are worn in both the pumps and the mixer. Leaks 
leading to changes in flow rate are usually easily detected and easily solved. 
COLUMN CONTAMINATION 
With continued use column packing generally changes its composition. Particles 
may become irreversibly attached to the silica and part of the bonded phase may be . 
removed through chemical attack. This results in long term changes in retention 
time. Toward the end of a column's life the retention time generally decreases and a 
loss of efficiency is seen, evidenced by band spreading, changes in peak area. 
Another malady of prolonged use is the increase over time of back pressure. This is 
due to partial blockage of the inlet frit. This was cleaned by reversing the column, 
and then flushing with a strong solvent to remove the particles, or by replacing the 
inlet :frit. 
TEMPERATURE CHANGES 
Temperature did affect the retention times .in this application. As laboratory 
temperature increased throughout the day, retention times decreased, and then 
increased again towards evening as the laboratory temperature decreased. As column 
temperature was not regulated, and it was not possible to control lab temperature, the 
column was insulated using a foam rubber sleeve, removing the effects of 
temperature-related changes in retention time. However, because the ratio of 
retention times between peaks did not change, the effect of temperature induced 
changes was minimal and did not prevent accurate sample analysis. 
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In addition to the above, changes in the area of the peaks was observed. These errors 
in quantification may result as a combination of the following: 
INJECTION TECHNIQUE . 
A manual injector has two modes, namely load and inject. In the 'load' position 
mobile phase passes directly from the pump to the column bypassing the injector 
loop. The constant volume loop is completely filled with sample, ensuring that an 
identical volume is injected, thereby reducing the variation. Once the loop has been 
completely filled the injector is turned to the 'inject' position, and the mobile phase 
from the pump is routed through the loop to the column. In this way sample is 
introduced easily and accurately into a high pressure system. 
However, the correct technique is critical for the injector to operate to its potential. 
With the rheodyne manual injector the microsyringe is inserted until the tip hits the 
surface of the seal. The plunger is then depressed so filling the constant volume 
loop. Without removing the needle the injector is turned from 'inject' to 'load', the 
syringe is then withdrawn. Originally the application required a 5µ1 injection and the 
20µ1 loop was only partially filled during each injection. This technique is difficult 
and often leads to volume inconsistencies, and should only be used with extremely 
concentrated samples where overload may occur. Once the procedure was modified 
to completely fill the loop consistency was greatly improved. Using this type of 
injector it is possible that cross-contamination occurs. That is, remnants of the 
previous sample remains in the injector and is introduced into the following 
chromatogram, producing spurious peaks. This was corrected by completely rinsing 
the injector with mobile phase A between runs. 
SAMPLE OR STANDARD DEGENERATION 
Large day-to-day variations in peak areas occurred as a result denaturation of 
calibration solutions, stored at room temperature. Once new solutions were divided 
into aliquots, sealed in 1.5ml reaction vials and frozen at -80 °C, reliability improved 
considerably. Standard solutions were thawed and vortexed mixed immediately prior 
to use. 
The OP A derivitised amino acids are unstable at room temperature, and the 
derivitisation, therefore, had to be standardised. 0-pthaldialdehyde was added to the 
sample and internal standard in a 1.5ml reaction vial. This was vortexed for ten 




The application in this study used a fluorometric detector to quantify and qualify 
amino acid content of the eluent. The fluorometer increases both selectivity ( only 
fluorescent species are observable) and sensitivity depending on the nature of the 
compounds and of the mobile phase. Fluorometers work on the principle that when a 
molecule absorbs energy it moves to a higher energy state. When returning to a more 
stable state they release energy in the form of light. 
Fluorometric detectors measure changes in the fluorescence of the column eluent 
when it is exposed to selected wavelengths oflight. Dissolved oxygen in the mobile 
phase results in quenching of the emitted fluorescence, so artificially decreasing 
component areas. Once all samples and mobile phases were degassed sufficiently 
some variability was removed (also improving pump performance). Degassing 
removes air bubbles resulting in a constant flow rate. Quantitation especially in a 
gradient system, was also improved as each band appeared exactly on the same point 
on the gradient in successive runs. Salt build-up and leaks will, for the same reason, 
interfere with quantitation. 
ADDITIONAL CONCERNS 
Over and above the difficulties already.described additional problems were 
experienced. Although the application could satisfactorily resolve all ten essential 
amino acids in 30 minutes, it was decided that these ten would not satisfy all the 
requirements of the department. Therefore it was decided that a new technique 
should be developed and a new 
standard amino acid kit (LAA-21, 
Sigma Chemical Company, St. Louis, 
MO 63178) containing all 20 amino 
acids, was purchased. Using OP A 
derivitisation it was not possible to 
detect or quantify hydroxy-proline or 
proline, leaving 18 quantifiable amino 
acids. 
TABLE 3 .3. Co-elution of amino acids using 
the technique of Turnell and Cooper {1982), in 
the present study. 
Amino Acids Time 
Glutamine & Histidine 3.5 mins. 
Alanine & Arginine 6.3 mins. 
Valine & Methionine 10.9 mins. 
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Once a standard 'cocktail' of these amino acids had been analysed a chromatogram of 
14 peaks was produced. After spiking successive runs with the single amino acids it 
was determined that six amino acids were co-eluting (Table 3.3). 
Believing that this poor resolution was a consequence of column degeneration the 
column was regenerated by flushing with the following solvents for five minutes 
each, in this order: 
i) 50 ml HPLC-grade water at 55°C, 
ii) 50 ml methanol, 
iii) 50 ml acetonitrile, 
iv) 30 ml tetrahydrofuran, 
v) 25 ml methanol and 
vi) 25 ml mobile phase. 
This succeeded in reducing back pressure but had no effect on resolution. After 
much manipulation it was decided that given the current application it was not 
possible to resolve all 18 peaks, and a new application was implemented making use 
of a different combination of solvents (Turnell and Cooper, 1982). This immediately 
improved resolution but lengthened each run to an hour. 
In order to improve resolution further (there continued to be overlap) the gradient 
program was systematically changed. After manipulation of both flow rate and 
gradient the separation was eventually optimised. Valine and methionine, however, 
continued to overlap. Analysis of samples from the present study on an amino acid 
autoanalyser (Beckmann Amino Acid Autoanalyser, Beckmann Instruments Inc., 
Brea, CA 92621) showed that methionine concentration does not change as a result 
of the exerc_ise protocol. In addition methionine is only 5% of the concentration of 
valine (0.0015 mM vs. 0.26 mM), and the valine concentration is therefore expressed 
as the summed values of valine and methionine concentration throughout the 
experiment. 
In a final attempt to improve resolution the length of the column was increased. This 
improved the efficiency of the column, resulting in narrower, better defined peaks. 
3. 7 Summary: 
The application produced the trace shown in Fig 3.1, which is the trace for the 
standard cocktail solution used to calibrate the machine. In the analysis of the 
41 
sample the peaks for valine and methionine overlapped, but apart from this the trace 
was identical. Development of this application for analyzing plasma amino acids 
took far longer than anticipated though, largely as a result of a number of 
fundamental errors being committed throughout method development. However, the 
value of developing the technique from first principles enhanced my knowledge of 
the apparatus, and at completion I am confident that the technique was both precise 
and accurate (see Table 3.4). The specifics of the HPLC apparatus used in this 
experiment are described in detail in the methods on 52. 
TABLE 3 .4. Calibration data for the HP LC method. Two 
calibrations were performed prior to analysis (see section 3.5) 
Number Calibration Calibration Average 
1 2 
1 57 950 57 461 57 706 
2 39 625 40 873 40 249 
3 43 809 41275 42 542 
4 54 583 52 542 53 415 
5 44 465 48 225 46 345 
6 68 610 67 904 68 257 
7 54 889 52 801 53 845 
8 56 721 58 162 57 442 
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Experimental Section: 
Chapter 4 - The Effect Of BCAA Ingestion on Physical 
Performance F'ollowing Prolonged Exercise 
4.1 Introduction: 
Previous studies have conclusively demonstrated that prolonged endurance exercise 
promotes the decline in plasma concentration of BCAA's, while plasma total 
tryptophan concentration either increases or does not change (Table 2.2). As a result, 
serum TRP:BCAA increases over time, resulting in an increased transport of 
tryptophan into the brain. Within the brain tryptophan is then hydroxy lated and 
decarboxylated to form serotonin. Elevated levels of serotonin are, according to the 
hypothesis, thought to increase the perception of both physical and mental effort 
during prolonged exercise. 
Certain studies have investigated the influence of altered serotonin concentrations on 
exercise performance, in both experimental animals and in humans. These studies 
have either manipulated brain serotonin indirectly, by altering plasma tryptophan 
concentrations (Fernstrom and Wurtman, 1974b, Okamura et al., 1987), or drugs 
have been used to alter brain serotonin concentrations directly (Bailey et al., 1992; 
Wilson and Maughan,1992; Bailey et al., 1993). However, because oflimitations in 
design and because of insufficient controls, results from these studies are 
inconclusive, and many questions, therefore, remain unresolved. 
The present study investigated the effects of prolonged submaximal exercise on 
physical and mental performance in eight trained cyclists. The exercise protocol was 
designed to produce a decline in serum BCAA concentrations, and then to reverse 
this decline by administering a BCAA supplement. Finally, the effects of this 
supplementation on physical and mental performance were examined. 
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4.2 Materials and Methods: 
4.2.1 Introduction. 
· To test the hypothesis of this thesis, eight trained cyclists participated in an exercise 
trial. Subjects rode for four hours at 55% of their V02 max, and then transferred to 
their own cycles, mounted on a windtrainer, where they completed a 40km time trial 
at maximal effort. Subjects ingested different drinks: 
i) CHO, 
ii) CHO + BCAA, and 
iii) BCAA 
during three randomised consecutive trials, one week apart. Physical performance 
was defined as the time taken to complete a 40km time trial, while mental 
performance was assessed before the exercise trial and after the time trial, using a 
computer-based Sternberg reaction-time test. 
.4.2.2 Subjects. 
Eight trained male cyclists were selected for this study. All subjects were informed 
of the purpose and nature of this study, and the experimental protocol was approved 
by the Ethics and Research Committee of the University of Cape Town, Medical 
School. 
In order to qualify for participation subjects were required to be currently training 
more than 250 km/week, for the past four weeks, and had to have completed a major 
local race (The 1992 Argus Cycle Tour) of 105 km in less than 3Yi hours. Subject 
characteristics are presented in Table 4.2, pg. 56. 
Body Composition 
The percentage body fat, height and mass of the subjects was measured before the 
first trial. Body mass, in addition, was determined before all three trials, prior to 
urination. Since all subjects were weight stable, values reported in Table 4.2 are an 
average of three measurements. Bicep, tricep, subscapular and supra-iliac skinfolds 
were measured with Holtain skinfold calipers (Holtain Ltd., Crosswell,-UK), and 
body density and percentage body fat was predicted using the equations of Durnin 
and Womersley (1974) and Brozek et a/.(1963): 
D = 1.1631-(0.0632 x log sk) 
& 
4.570 
% Fat= 100(1:)-4.142) 
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(Durnin and Womersley, 197 4) 
(Brozek et al., 1963) 
D= the predicted density of the body (g/ml), for males between the ages of 19 .2 and 29 .1 yr. of age, 
and log skis the log of the sum of the 4 skinfold measurements. 
4.2.3 Preliminary Tests. 
At least one week before the first trial, each subject performed an incremental 
exercise test to exhaustion to determine the maximal oxygen consumption (V02 
max). In this trial, starting work load was 3.33 W/kg, and work rate was increased 
by 25 W every 2Yi minutes. During the test subjects wore a noseclip and breathed 
inspired air via a Hans Rudolph #2700 non-rebreathing valve (Vacumed, Ventura) 
connected to a dry gas meter. Expired air was passed through a 15 litre baffled 
mixing chamber and a condensation coil. Exhaled air was drawn into oxygen 
(Ametek, S-3AJII, Thermox Instruments, Pittsburgh, PA) and carbon dioxide 
analyzers (Ametek, S-3AJII, Thermox Instruments, Pittsburgh, PA) at a constant 
flow-rate of 5ml/min by two flow pumps (Ametek, 12-0010, Thermox Instruments, 
Pittsburgh, PA). The analyzers were connected to sensors, which detect changes in 
02 and CO2 concentrations (N-22M and P-61B, Thermox instruments, Pittsburgh, 
PA). V02, CO2 production and RER were calculated using conventional formulae 
(Consolazio et al.1963). 
Velodyne 
Following the determination ofV02 max, all subjects (n=6) who had not previously 
ridden the Schwinn Velodyne Cyclosimulator (Schwinn, Chicago, USA) windtrainer 
completed a familiarization ride. The Velodyne, an indoor trainer onto which a 
subject's own bicycle can be mounted, simulated road cycling. Work rate is adjusted 
by a load applied to the rear wheel. The work load applied takes into account the 
cyclist's weight and frontal surface area, in order to simulate cycling conditions as 
closely as possible. 
The Velodyne was calibrated prior to each trial following a warm-up of at least thirty 
minutes. To calibrate each subject's bicycle was mounted to the trainer, a constant 
weight was placed on the rear wheel and the axle was tightened. The subject then 
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pedaled smoothly to a speed of 40 km/hr, stopped and allowed the speed to decrease 
below 8 km/hr. The rider again pedaled to 40 km/hr and stopped. Computer 
software then used these two sequences to calculate a speed to power calibration 
curve. Thereafter, the subject rode a 40km time trial at maximum effort. The work 
load set on the Velodyne has proved to be accurate to within ±5% (Kyle, 199.l ). 
4.2.4 Experimental Protocol. 
As meal content, prior to exercise, was likely to be important in this experiment the 
two meals prior to each exercise trial were standardised in order to eliminate any 
inter-individual differences. The meal eaten the night before each trial was 
standardised for each subject, that is, each subject selected a dinner, and an identical 
meal was eaten on the night before each subsequent trial. On the morning of the 
trial, three different isocaloric breakfasts were offered (see section D). The 
breakfasts content was designed by a dietitian and contained identical proportions of 
carbohydrate, fat and protein. Different breakfasts were available in order to allow 
each subject to select a meal palatable to himself. 
Each trial was separated by one week, and was conducted at the same time on the 
same day of the week. This was an attempt to standardise conditions in the two days 
preceding the trial, for each subject. Subjects were also required to record their 
training during the three weeks and report any changes in volume or intensity. 
Sternberg test 
REVIEW OF THE LITERATURE 
The Sternberg reaction-time test was selected to quantify mental fatigue following 
each exercise trial (Sternberg, 1966). The test was chosen over the Stroop colour 
word test, which had been used previously (Blomstrand et al., 1989) as it is of shorter 
duration, and is therefore more sensitive to detect small reversible changes in 
reaction time, post-exercise (Hosstetler, personal communication). In addition, this 
test does not exhibit a learning effect and is characterized by a low error rate (Smith 
and Langolf, 1981). Sternberg (1966), used this test to demonstrate how symbolic 
information is retrieved from memory, vfa a serial comparison process. The test 
determines the time taken for a subject to judge whether a test symbol is contained 
within a memorized sequence. He found that reaction times increased linearly with 
the length of the sequence. This test may therefore be used to study how cognitive 
function (mental awareness) changes as a result of prolonged exercise. The 
Sternberg test was deemed suitable for this purpose as it is both precise and well 
grounded in cognitive theory (Smith and Langolf, 1981 ). 
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The Sternberg reaction-time test uses letters of the alphabet as these are well learned 
and highly discriminable. A feature of this test is the low error rate which justifies 
the assumption that on a typical trial the subject's memory of the series presented is 
identical to the series presented by the test (Sternberg, 1966). In addition, the 
validity of the Sternberg test is fully proven by the fact that there is little or no 
learning effect and that only a short practice session is required by each subject prior 
to the test. 
MEIBODOLOGY 
Subjects performed the reaction-time test before each trial began and after the time 
trial in a closed silent laboratory. The test was performed on a microcomputer, using 
software developed by Mr. Frank Bokhurst of the Department of Psychology of the 
University of Cape Town . 
. In this task the subject is asked to memorize a sequence of either two or five letters. 
The test is classically performed with series containing one to six letters, but, it has 
been demonstrated that a test containing series of two and five letters is 
representative of the complete test (Smith and Langolf, 1981). 
Subjects selected their own true and false key on the computer keyboard, which they 
pressed with different hands, and prior to each session subjects completed a three 
minute practice session. 
Each test comprised the following: 
i) An auditory warning signal indicating the beginning of each series. 
ii) A series of either two or five letters. The length of each sequence was 
randomly chosen by the program. Each letter appeared on the screen for one 
second, immediately replaced by the subsequent letter. 
iii) Following a delay of one second the test digit appeared, remaining on the 
screen for one second. 
iv) Subjects were required to decide whether the test letter had appeared in the 
preceding sequence. Subjects responded as quickly as possible, by pressing 
the 'true' key if it had appeared in the sequence, and the 'false' key if it had not. 
Each trial comprised 60 test sequences of which approximately 30 were two digits 
long and the remainder five digits. 
Three mental performance measures are available as a result of this test: 
i) memory scanning time, 
ii) effect of response type, and 
iii) Y intercept. 
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The effect of response type deals with the difference between a 'yes' and 'no' answer 
while the intercept deals with the latency before making a response. Both of these 
factors are 'hard-wired', that is, they are unalterable characteristics of brain function 
and are not affected in the short-term by perturbations such as exercise. 
The reaction time pre- and post-exercise ( a measure of mental fatigue), which is 
quantified by the memory scanning time (i) may be affected by both an acute 
(endurance exercise) or a chronic (mercury poisoning) intervention (Smith and 
Langolf, 1981). 
Exercise Procedure 
Following the Sternberg reaction-time test subjects urinated to empty their bladders. 
This pre-exercise urine sample was stored on ice until analysis five to six hours later. 
A cannula, attached to a stop cock, was then placed percutaneously into a medial 
antecubital vein. Blood samples were drawn into a syringe via the stop-cock, and the 
cannula flushed with saline. Heparin was not used to maintain patency of the 
cannula as this may have induced lipolysis, artificially elevating plasma free fatty 
acid concentrations. Cannulae remained patent for most subjects, on most trials 
(n=l8), for the full hour between the collection of blood samples. In the event that 
the cannula became blocked, a new cannula was inserted, more medially, in the same 
vern. 
SUBMAXIMAL EXERCISE 
Subjects then began cycling on a stationary electronically braked cycle ergometer at 
55% of their previously determined V02 max value. After an hour on the ergometer 
subjects were allowed a five minute rest, during which time they were permitted to 
urinate. This urine sample was collected together with any other produced over the 
remainder of the trial and the pooled urine sample formed the exercise-urine sample. 
Urinary urea and creatinine were determined in the pre- and during-exercise samples. 
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Subjects then rode for 55 minutes at which time they again rested for five minutes. 
This was repeated twice for a total exercise time of four hours. Blood was collected 
every hour, prior to the five minute rest, and then again, within five minutes, 
following completion of the 40km time trial. During the low intensity trial subjects 
were permitted to watch videos or listen to music. Each subject completed four 
hours at this intensity, after which time they moved to their own bicycle mounted on 
the V elodyne. 
TIME TRIAL 
The Velodyne was quickly calibrated and the subjects began a forty kilometer time 
trial, not less than ten and not more than fifteen minutes after finishing the four hour 
ride. Heart rate was measured every five seconds using a Polar Vantage pulse 
monitor (Polar USA, Stamford, CT). 
Subjects were isolated in a small, temperature constant laboratory (22°C), for the 
time trial, where no external motivation was available. Subjects were aware of the 
current speed and distance covered on the Velodyne, and were therefore able to pace 
themselves accordingly. 
Drinking Regimen 
Each subject participated in three trials, one week apart, during which he received 
one of three different drinks per trial. Trial order was randomised, and all 
experiments were conducted in a single blind manner, with only the investigator 
aware of drink content. 
Immediately preceding each trial, subjects received a 400 ml drink bolus, and then 
drank a further 100 ml every 15 minutes. In the time trial 100ml was given before 
starting, and a further 100 ml was given every 15 minutes until completion of the 
40km time trial. The drink was supplied in all cases by the same investigator and no 
encouragement was given throughout the time trial. 
The drinks consisted of the following: 
i) CHO - 10% carbohydrate solution (Leppin glucose polymer v/v) 
ii) CHO/BCAA- a 10% carbohydrate solution plus 0.156% branched-chain 
amino acid mixture. 
iii) BCAA- a 0.156% branched-chain amino acid mixture. 
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The BCAA mixture contained the three branched-chain amino acids; valine, leucine 
and isoleucine in the proportion 3 :2: 1. This ratio was selected as it approximates the 
distribution ofBCAA's in the blood (Frame, 1958). The drink contained, per litre, 
781.5mg of val, 521.0mg ofleu and 260.5mg of ile. Subjects therefore received 
1.250g BCAA during the first hour and 0.625g per hour for the following three hours 
and the time trial. Drinks were chilled, were palatable and tasted similar enough to 
prevent identification. This was determined prior to the experiment in a small test 
using laboratory personnel (n=5). In addition, subjects were unaware of the possible 
drink content until completion of all three trials. The BCAA solution was sweetened 
with a sugar-free concentrate. 
Additional Measurements 
Expired air was collected from the subjects, every 20 minutes, for the determination 
of oxygen consumption (V02), and respiratory exchange ratio (RER). Ratings of 
perceived exertion (RPE), for general muscular fatigue was performed using the Borg 
scale (Borg, 1982) (Appendix B) and heart rate, recorded via telemetry on a Polar. 
Vantage (Polar USA, Stamford, CT) cordless heart rate monitor, were noted, every 
30 minutes. For the duration of the time-trial heart rate was recorded every five 
seconds, and this was later downloaded via a Polar interface (Polar USA, Stamford, 
CT) to a computer. 
4.2.5 Blood Sampling. 
Ten millilitres of blood per sample was drawn and this was decanted into four 
vacutainers containing different active ingredients. The first, containing heparin, was 
used for the determination of the haematocrit and haemoglobin concentration, the 
second containing ethylenediamine tetraacetate (EDTA) for the determination of 
ammonia concentration, the third, sodium fluoride for plasma glucose determination 
and the fourth promoted coagulation of the blood in order to obtain serum for the 
subsequent measurement of serum amino acids, free fatty acids, glycerol and insulin 
concentrations. 
The heparinised blood was immediately placed on ice. The blood being used for the 
determination of ammonia and-glucose concentrations was centrifuged at 1500 rpm 
for ten minutes. The supernatant for each sample was withdrawn, placed in sterile 
1.5 ml reaction vials, sealed with parafilm and placed on ice. The fourth tube was 
allowed to coagulate at room temperature and then centrifuged at 1500 rpm for ten 
minutes. The supernatant was then treated as described above. 
Later the same day haematocrit, haemoglobin and plasma ammonia concentrations 
were measured. The remaining blood was frozen at -80°C until later analysis. 
4.2.6 Biochemical Assays. 
Haematocrit 
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Whole heparinised blood was kept on ice, for between one and four hours, until 
haematocrit determination. For each sample two microcapillary tubes were filled, 
and sealed with putty at one end. Tubes were then placed in a microcentrifuge and 
spun at 11 500 rpm, for five minutes. Haematocrit was calculated as the ratio of red 
blood corpuscles to plasma volume. 
Haemoglobin 
Twenty micro litres of whole heparinised blood was added to 5ml of cold Drabkin's 
solution (Hainline, 1958) (Appendix C). This tube was then inverted a number of 
·times and then allowed to stand for 20 minutes. Samples were then read at 540nm in 
the visible range on a spectrophotometer (Beckmann Instruments Inc, Brea, CA 
92621 ). Haemoglobin concentrations were calculated by comparing resultant sample 
absorbances against a standard curve. The standard curve was derived, for each 
assay, by reading the absorbance of three standards (Sigma Chemical Company, St. 
Louis, MO 63178). Standards with concentrations of 50, 100 and 200 g/1 were 
measured direct! y. 
Plasma volume 
Changes in plasma volume were calculated according to the method of Dill and 
Costill (1974). Plasma volume was calculated from values ofhaematocrit and 
haemoglobin concentrations, using the relations below. The subscripts Band A refer 
to before and after exercise respectively. 
Hba 
BVA = BVa(-) 
· HbA 
CVA = BVA(HctA) 
PV A = BV A - CV A 
BV = blood volume, CV = cell volume and PV = plasma volume. 
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Ammonia 
Blood for this assay was collected into a vacutainer containing ethylenediamine 
tetraacetate (EDTA). Blood was mixed and centrifuged within 15 minutes. 
Ammonia assays were performed using a kit (#125857, Boehringer Mannheim, 
Mannheim, Germany). This assay was modified by placing 150µ1 of sample into a 
cuvette containing 0.75ml of buffer. This was mixed and allowed to stand for ten 
minutes, before reading the absorbance (Al). Six microlitres of suspension 2 (from 
the kit) was then added, and the absorbance was again read after ten minutes (A2), 
after which a further 6µ1 of suspension 2 was added. The final absorbance was then 
read after ten mins. (A3) and ammonia concentration was calculated as follows: 
(Al- A2)-(A2- A3) = Msample I blank 
and 
M sample x 959 = Ammonia concentration (µmol / L) 
(959 = Extinction co-efficient corrected for the dilution). 
Glucose 
Glucose concentrations were determined from plasma in which glycolysis had been 
terminated through the use of sodium fluoride. Glucose concentrations were 
determined in duplicate, on a glucose analyser 2 (Beckmann Instruments Inc, Brea, 
CA 92621 ). Prior to glucose concentration determination the analyser was 
calibrated, using an 8 mmol/1 Beckmann standard (Beckmann Instruments Inc, Brea, 
CA 92621). The analyser was recalibrated after every 12 samples. Each sample was 
thawed once and thoroughly mixed prior to glucose concentration determination. 
Other biochemical assays 
Serum was also analysed for free fatty acid (Kit# 1383175, Boehringer Mannheim, 
Mannheim, Germany) and glycerol (Kit# 148270, Boehringer Mannheim, 
Mannheim, Germany) concentrations. Insulin concentration was determined using 
radio-immuno assay (Pharmacia Diagnostic, Insulin Kit, Uppsala, Sweden). Urea 
and creatinine concentrations were determined using a Beckmann multi-channel 
analyser (Beckmann Instruments Inc, Brea, CA 92621 ). 
Calculation of TRP:BCAA ratio 
This important parameter was calculated individually for each subject at each time 
point, as follows: 
TRP:BCAA - [TRP] (mmol/1) 
[VAL ]+[LEU]+[ILE] 
4.2. 7 High Performance Liquid 
Chromatography. 
TABLE 4 .1 List of amino acids 
The concentrations of 17 amirio acids were 
measured (Table 4.1) using an HPLC. Serum was 
collected and stored as described above at -80°C 
until analysis. 
Apparatus 
A Gilson gradient HPLC system (Gilson Medical 
Electronics, Villiers-le-Bel, France) was used for 
the determination of serum amino acid 
concentrations. Samples were injected through a 
rheodyne valve #7125 (Rheodyne Inc. Cotati, CA 
94928), fitted with a 20µ1 loop. A 250 x 4.6 mm 
internal diameter analytical column, pre packed 
with 5µm diameter Hypersil C18, was used.- No 
measured on the HP LC with their 
~ommon abbreviations. 
Amino Acid Abr. 
1. Aspartate ASP 
2. Glutamate GLU 
3. Asparagine ASN 
4. Serine SER 
5. Histidine HIS 
6. Glutamine GLN 
7. Glycine GLY 
8. Threonine THR 
9. Arginine ARG 
10. Alanine ALA 
11. Tyrosine TYR 
12. Valine VAL 
13. Tryptophan TRP 
14 Phenylalanine PRE 
15. Isoleucine ILE 
16. Leucine LEU 
17. Lysine LYS 
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guard column was used, but all samples and reagents were thoroughly filtered with 
0.45µm pore size filter (Millipore Intertech Inc., Bedford, MA 01730). Detection of 
derivitised amino acids was achieved with a Gilson 121 fluorometer, excitation 
wavelength 380nm and emission cut-off filter at 450nm. Data was analysed using 
Gilson software (Gilson Medical Electronics, Villiers-le-Bel, France) on a 
microcomputer. 
Reagents 
All standard amino acid powders were obtained from Sigma Chemical Company (St. 
Louis, MO 63178). Acetonitrile, methanol, proprionic acid (HPLC grade) and di-
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sodium hydrogen phosphate (uniV AR grade) were obtained from Saarchem Pty Ltd. 
(Observatory, Cape Town 7925). Double-distilled, deionised water was used in the 
preparation of all solvents, reagents and standard solutions. 
OPAIMCE REAGENT 
This reagent (# P-0532) was bought already constituted from Sigma Chemical 
Company (St. Louis, MO 63178). This reduced inter-assay variability due to 
possible differences in make-up of the derivatising agent. The o-pthaldialdehyde/2-
mercaptoethanol solution was stored at± 4 °C. 
AMINO ACID STANDARDS 
A standard cocktail solution of 17 amino acids was mixed to calibrate the HPLC. 
Five hundred µmol of each amino acid was dissolved in lL of water. This solution 
was then divided into aliquots, placed in 1.5 ml reaction vials, sealed with parafilm 
and frozen at -80°C. 
INTERNAL STANDARD 
Methionine sulfone was selected as the internal standard. 15µmol of this amino acid 
was dissolved in water, and the solution was then divided into aliquots, sealed and 
stored at -80°C. 
PRECIPITATION REAGENT 
Serum protein was precipitated using an acetonitrile reagent. This reagent was made 
up daily by adding 1 Oµl of mercaptoethanol to 5 ml acetonitrile. 
SOLVENTS 
In a gradient system two solvents are used to facilitate the separation of the 
components of interest. In this application the solvents are constituted as follows; 
• Solvent A: water/stock sodium proprionate/acetonitrile (72/20/8 by vol.) 
pH=6.50 ± 0.1 at room temperature. 
• Solvent B: water/acetonitrile/methanol (45/30/25 by vol.) 
The stock solution contains, per litre, 350 mmol di-sodium hydrogen phosphate and 
250 mmol proprionic acid (p=0.990-0.995 kg/L). All solvents were filtered with 
0.45µm Millipore cellulose filters (Millipore Intertech Inc., Bedford, MA 01730) and 
degassed thoroughly in a vacuum. The gradient program is shown in figure 4.1. 
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Procedure 
Both filtered standards and samples were stored at -80°C and thawed immediately 
before analysis. 
DERIVITISA TION 
Each sample was 
derivitised by adding 
150µ1 of the 
acetonitrile 
precipitation mixture 
to 20µ1 of the sample / 
standard solution. 20 
µl of methionine 
sulfone, the internal 
standard was then 
added. This was 
100 
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FIGURE 4.1 The gradient profile for the determination of serum amino 
acid concentration. An isocratic hold of solvent A is maintained for 10.5 
minutes, and then B is gradually introduced until at 40 mins. 100% of B is 
maintained for 5 minutes. At 45 mins. 100% of A is reintroduced, re-
equilibrating the column. 
vortex mixed and centrifuged at 11 500 rpm for two minutes to remove the protein 
precipitate. Twenty micro litres of the supernatant was then pipetted into a separate 
tube and 100µ1 of the OPA/MCE reagent was added. This was vortex mixed for ten 
seconds and exactly one minute after mixing the sample was injected, using a 5 µl 
syringe (SGE A-rn, Victoria 3134, Australia). Three times the loop's volume was 
injected to ensure that the 20µ1 loop was completely filled. The sample was 
introduced slowly and evenly to prevent the creation of air bubbles, which alters 
sample volume. Finally, the delay between derivitisation and injection was constant, 
at one minute, as OP A derivatives tend to be unstable at room temperature in these 
solvents (Turnell and Cooper, 1982). 
QUANTIT A TION 
Amino acids are identified through their retention times relative to the internal 
standard, methionine sulfone . . During method development a standard solution was 
used to identify peaks. This standard 'cocktail', containing all the amino acids in 
equal concentrations of 500µmol/L, produces a chromatogram with 17 peaks. The 
identity of each peak was, however, at this stage unknown, and an additional 17 runs 
were therefore required to identify each peak. In each of the 17 runs an additional 
20µ1 of one of the amino acids was added. This 'spiking' resulted in one extra-large 
peak, the identity of which was known. In this way each peak in the chromatogram 
was identified, and then because retention times remained constant, with respect to 
the internal standard, qualification was possible. 
QUANflFICA TION 
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The area under each peak is proportional to the amount of the component in the 
sample, which allows the calculation of the concentration of each amino acid. Area 
under the curve for each peak was calculated by the Gilson Software (Gilson Medical 
Electronics, Villiers-le-Bel, France). A number of calibration runs were performed 
and from this a standard curve was produced. Using this curve the concentration of 
each amino acid was calculated. Concentrations of each amino acid are expressed 
relative to the area of the internal standard to ensure that differences in both injection 
volume and derivitisation are accounted for. 
Operation 
High performance liquid chromatography is an extremely sensitive technique. To 
ensure accuracy and precision it is therefore necessary to perform a calibration before 
attempting to analyse samples. Each calibration run was performed in the same 
manner as a sample run, with the exception that the sample was replaced by a 
standard 'cocktail' solution containing the amino acids of interest (see Table 4.1). 
The calibration solution was treated identically to the sample and information from 
the two runs is averaged and used to create a standard curve. If a coefficient of 
variation greater than 5% existed between two calibrations the calibration was 
repeated. Following the calibration a maximum of 12 samples were run before 
recalibration. 
4.2.8 Statistics. 
Samples were recorded throughout the low intensity ride and then upon completion 
of the time trial. Even though finishing time was different for all subjects, these are 
reported as 300 minutes in all graphs and tables, to allow for comparisons between 
subjects. Statistical tests were processed using Statgraphics statistical software 
package (STSC inc., Rockville, Maryland 20852), on an IBM compatible 386-SX 
personal computer. A two-way repeated measures analysis of variance (AN OVA) 
was performed to detect changes over time in biochemical, performance and · 
psychological variables on different treatments. A one way repeated measures 
analysis of variance (ANOVA) was used to assess differences in cycling time 
between trials (Snedecor and Cochran, 1980). A paired T-test was used to determine 
differences between measurements pre- and post-exercise. When overall significance 
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occurred, a Scheffe's post-hoc test was performed to detect specific differences 
(Snedecor and Cochran, 1980). Statistical significance was accepted at the 5% level 
(p~0.05). Levine's test for homogeneity of variance (Snedecor and Cochran, 1980) 
was performed on the physical performance and on the Sternberg data, to co~ 
that variances were equal, this being one of the assumptions for the use of parametric 
statistics. All data are expressed as means ± standard error of the mean. Standard 
error bars are consistently shown on only two of the three curves on each graph. This 
was done as no differences existed in any of the standard errors for any of the curves 
(see Appendix A for raw concentrations), and it permitted improved visualization of 
the data. 
4.3 Results: 
All Figures and raw data not included in the text may be found in Appendix A. 
TABLE 4 .2 Demographic data for the 
eight test subjects. 
Variable Mean±SE 
Age (yrs.) 25.0 ± 3.3 
Height (cm)· 182.l ± 5.9 
Weight (kg) 79.5 ± 7.0 
%Fat IO.I± 2.1 
V02max 61.9 ± 4.3 
(ml 02/kg/min) 
4.3.1 Subjects. 
Body fat% (10.1 ± 2.1%) and V02 max 
(61.9 ± 4.3 ml/kg/min) in this study group 
was normal for a trained athletic 
population (McArdle, et al., 1991 ). None 
of the subjects reported a significant 
change in their training volumes or 
intensity for the duration of the study. In 
addition, in an attempt to standardise pre-trial intake each subject was required to eat 
the same dinner and breakfast the evening and morning before the trial. All subjects 
adhered to this directive as confirmed by pre-exercise questionnaires (see Section 
4.24}. 
4.3.2 Amino Acids. 
The serum concentration of many of the amino acids changed during prolonged 
endurance exercise. In addition the concentration of certain serum amino acids 
changed differently depending upon treatment. All amino acid concentrations are 
expressed as a percentage of the resting value as there were large intra and inter-
. - individual differences in absolute resting values. By expressing the concentration as 
a percentage these differences are minimized and variation is reduced. Absolute 
values may, however, be found in Appendix A. 
Serum amino acid concentrations. 
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The concentrations of 
aspartate, histidine, 
phenylalanine (all in 
Appendix A - Table A.1 ), 
glutamine, glutamate (Fig. 
4.2 B) and tryptophan (Fig. 
4.2 A) did not change over 
time for the duration of the 
test. Nor were there any 
differences in amino acid 
concentration between the 
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FIGURE 4.2B Serum glutamine and glutamate concentrations do not change in any of the trials. 
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FIGURE 4.3 Serum BCAA (leu, ile and val) 
concentrations during prolonged exercise. * denotes 
a significant difference in amino acid concentration, 
in the CHO trial, compared to the resting values in 
that trial (p:51J.OJ), and the# denotes a significant 
difference between the CHO only trial and the other 
two trials at 300 mins. (pS0.05). 
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DECREASE IN AMINO ACID CONCENTRATION 
The concentration of asparagine, glycine, threonine, arginine, alanine, tyrosine, 
valine, isoleucine, leucine and lysine decreased significantly, in at least one of the 
three trials, over the duration of the exercise test (p:$;0.05). 
Arginine and tyrosine decreased significantly only in the CHO + BCAA 
trial, while lysine decreased in both the CHO + BCAA and the BCAA trial. 
In the CHO only trial the concentrations of all three BCAA's - valine, isoleucine and 
leucine - decreased progressively for the duration of the trial, and this became 
significant at 120 mins. oflow intensity exercise, in all three trials (p:$;0.01). In 
additio~ all three BCAA concentrations post-exercise were significantly lower in 
the CHO trial, compared to the other two trials containing the BCAA supplement. In 
the CHO+ BCAA trials serum BCAA concentrations were not significantly different 
from the resting values in any of the trials. 
Ratio of TRP:BCAA 
0 .3 0 CHO 
• CHO+BCAA 
0 60 120 180 240 300 
Tim e ( m ins) 
FIGURE 4.4 Change in TRP:BCAA over the duration of the 
exercise trial. • denotes a significant difference in the CHO trial 
compared to resting values and to the other two trials (pS0.05). 
4.3.3 Physical Performance 
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Fig 4.4 shows that the 
TRP:BCAA ratio 
increases in the CHO 
trial, but does not change 
in the CHO + BCAA and. 
BCAA trials. This 
difference becomes 
significant at 180 minutes 
and this maintained for 
the remainder of the trial. 
The time taken to complete a 40km time trial was not significantly different whether 
subjects ingested CHO only, CHO+ BCAA or BCAA's only (Table 4.3). Time was 
measured on the Velodyne, in minutes and seconds. 
TABLE 4.3 Mean 40km time trial time under three 
test conditions. 
Trial Time (mins.: secs) 
CHO 68:59 ± 6:02 
CHO+BCAA 68:00 ± 3.02 
BCAA 69:44 ± 5.39 
4.3.4 Blood Variables. 
Serum amino acid and serum glycerol and ammonia concentrations displayed a large 
inter-individual difference. For this reason these variables have been expressed as a 
percentage change. However, the absolute and the normalized values have been 
presented for scrutiny (Appendix A). 
Haematocrit and Haemoglobin 
Mean resting haematocrit values were 44.3% ± 2.3%, 44.6% ± 1.2% and 45.1 % ± 
1.6% for the CHO, CHO+ BCAA and BCAA trials respectively. Haematocrit 
increased significantly over the five hours of the trial, while haemoglobin 
concentrations increased similarly in all trials, until completion of the time trial. 
Haemoglobin values were used to calculate the change in plasma volume over the 
duration of the trial (Dill and Costill, 1974). 
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Plasma volume decreased similarly in all three trials. The differences between trials 
(-8.4 ± 0.2 CHO, -9.4 ± 0.1 CHO+ BCAA &-6.3 ± 0.3 BCAA) were non-
significant, and for this reason the concentrations of the blood-borne variables have 
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greater in the CHO 
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trials compared 
with the BCAA 
trial (p~0.01). The 



































FIGURE 4.5 Percentage change in plasma ammonia concentration. 
Values are calculated as a percentage of the resting values. * denotes a 
significant difference compared to the BCAA trial and to resting values (pS 
0.01) 
the CHO and the CHO + BCAA trials were also significantly greater than the resting 
values following the time trial (p.$;0.01). 
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for all three trials, but 
rose significantly , 
compared to resting 
values, in the CHO 
and CHO+ BCAA 
trials following the 
time trial (p~0.01). 
Also, glucose 
concentration was 
significantly greater in 
the CHO and CHO + 
Time (mins) 
FIGURE 4.6 Plasma glucose concentration. * denotes significant 
increases above resting values (p51J.OJ), and above the BCAA trial (pS 
0.05). 
BCAA trials than that 
in the BCAA trial at 300 mins. (p~0.05). 
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FIGURE 4.7 Serum insulin concentration decreased 
significantly in all three trials. * denotes a significant 
difference in all three trials compared to resting values. 
Insulin 
The insulin concentrations 
decreased similarly from 
resting values for all three 
trials, becoming significant 
at 120 minutes (p~0.05). 
No differences exist 
between any of the trials 
for the decline in insulin 
concentrations. 
Free Fatty Acids 
Serum free fatty acid 
concentrations 
increased with time 
(p<0.05), in all three 
trials compared to 
resting values (Fig 
4.8). Following the 
time trial FF A 
concentrations in the 
BCAA trial were 
significantly higher 
than those in the 
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FIGURE 4.8 Serum free fatty acid concentrations. * indicates 
a significant difference between FFA 's in all three trials 
compared to resting values (p;S;(). 05). # denotes significance at 
300 mins. between the BCAA trial and the other two (p;S;().01). 






The percentage change in 
serum glycerol is shown in 
Fig 4.9. From 180 minutes 
onwards glycerol levels 
increased above resting 
values, in the BCAA trial 
only (p~0.01). Glycerol 
concentrations did not 
change in the CHO and 
CHO + BCAA trials, with 
regard to resting values. 
The percentage change in 
glycerol was also 
FIGURE 4.9 The percentage change in glycerol concentration. * significantly increased in 
indicates a significant difference in all three trials from resting values the BCAA trial, compared 
(p;S;().01), and# indicates a difference between the BCAA trial at 300 
mins. compared to the CHO and CHO+ BCAA trials (p;S;().05) to the other two, at 300 
mins. (p~0.05). 
Urea and Creatinine 
'-
0. 12 
0 . 11 
0 . 10 
~ 0 .09 
~ 0 .08 
C 
.Q 














































Pre Exercise Exercise Pre Exercise Exercise 
Figure 4.10 Urea and creatinine levels in urine. * indicates significance between pre- and during 
exercise values (p.51J.05). 
The urinary urea and creatinine concentrations were significantly increased in the 
exercise sample compared to the pre-exercise sample. The increase, for urea, was 
significant for the CHO + BCAA and BCAA trials only (p~0.05). While urinary 
creatinine concentration increased significantly in the exercise sample, in all three 
trials. No differences occurred between the three trials for either urea or creatinine. 
4.3.5 Sternberg Test . 
The response to the test 
sequence is either 'true' (test 
digit appeared in the 
sequence) or 'false' ( digit does 
not appear). It has been 
shown that there is no 
difference in reaction time, 
between 'true' and 'false' 
responses (Smith and 
Langolf, 1981), and data from 
these has been combined. 
The change in reaction time 
is the only parameter of the 
three discussed previously 
(memory scanning time - see 
pg.46)thatchanges 
1000 
D Pre exercise 
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FIGURE 4.11 Changes in reaction time following prolonged 
exercise. Data shown is for time taken to react to a series 
containingfIVe digits (see text) . 
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exercise), and this parameter was measured both pre- and post-exercise. Fig 4.11 
shows the effect of prolonged exercise on reaction times, which can be interpreted as 
short-term memory. Pre-exercise reaction time is indicated with an open bar, while 
reaction times following the time trial are shown with hatched bars. No significant 
differences were found between the pre- and post-exercise mental performance on the 
Sternberg reaction-time test. There does however appear to be a trend towards a 
faster reaction times post-exercise, especially in the BCAA-containing trials, see Fig 
4.11. The large inter-individual differences, produce large standard deviations, 
which prevents the data from reaching significance. As described by Smith and 
Langolf (1981) the error rate was very low, with all subjects making fewer than 3 
mistakes per 60 item sequence (5%). However, one must be cautious in interpreting 
results from a small population (n=8) as large inherent differences in scanning time 
exists between individuals. 
4.3.6 Cardiorespiratory Data. 
Oxygen 
consumption 




exercise for all 
trials (Fig 4.12). 
V02 fluctuated 
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over the duration 
of the trial. 
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FIGURE 4.12 Oxygen consumption throughout the low 
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FIGURE 4.13 The respiratory exchange ratio measured for the 
duration of the low intensity exercise bout. * indicates a significant 
decrease in RERfor the BCAA trial compared to rest and to the CHO 
and CHO+ BCAA trials(pSfJ.05), and# indicates a significant 
decrease compared to resting values, at 235 minutes in the other two 
trials (pS0.05). 
only achieved in the other two trials by 235 minutes. 

























The respiratory exchange 
ratio (RER), measured 
every twenty minutes for 
the duration of the low . 
intensity exercise, but not 
during the time trial, was 
significantly lower in the 
BCAA trial, compared to 
the CHO + BCAA and 
CHO trials, after 115 
minutes (Fig 4.13). Also 
at 115 minutes RER had 
decreased significantly 
from the resting values, 
in the BCAA trial. A 









Rating of perceived exertion 
Perceived exertion was 
measured in both the low 
intensity exercise and in the 
time trial. RPE increased 
throughout exercise, in all 
three trials (Fig 4.14). 
Perceived exertion increased 
above resting values after 180 
minutes in all three trials, and 
increased further in the time 
trial, in all three treatments. 
There was no difference in 
RPE, between trials, that is as 
a result of ingested drink. FIGURE 4.14 RPE in both the low intensity exercise and time trial. 
The break in the y-axis indicates the transition to the time trial. * 
indicates a significant increase in RP E in all three trials compared to 
resting values {pSfJ.05). 
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Heart rate 
The heart rate was similar for each treatment and ranged between 121 bpm and 136 
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FIGURE 4.15 Heart rate during the low intensity trial, was measured 
every 20 mins. . * indicates a significant increase compared to the first 
reading at I 5 mins. (pS0.05). 
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FIGURE 4.16 Average and maximal heart rates during the time trial. 
minutes,increased 
significantly above the 
first measured heart 
rate at fifteen minutes 
(p:s;0.05), for all three 
trials. Heart rates, 
between treatments, 
were similar at each 
time point (Fig 4.15). 
In addition, no 
significant differences 
occurred for the 
average and maximal 
heart rates achieved 




The aim of this study was to investigate the hypothesis that an increase in the serum 
tryptophan to branched-chain amino acids ratio during prolonged exercise might 
impair physical performance, through the development of central fatigue. None of 
the previous studies investigating this hypothesis in humans, has been sufficiently 
rigorous to test the hypothesis completely. ~n addition, we attempted to quantify 
mental performance both pre- and post-exercise, as it has previously been shown that 
mental performance improves following the ingestion of a BCAA supplement 
(Blomstrand et al., 1991). 
Exercise induced change in TRP:BCAA ratio 
In order to test the hypothesis that an increased serum tryptophan could lead to 
central fatigue, the exercise had to be designed so that the serum TRP:BCAA ratio 
increased, producing a increased serum tryptophan, following prolonged exercise. It 
was also important that the TRP:BCAA did not change following ingestion of a 
BCAA supplement, so preventing an increase in the cerebral tryptophan 
concentration. 
This was achieved as the TRP:BCAA ratio in the CHO only trial increased 
significantly (Fig 4.4), suggesting an increased tryptophan transport into the brain 
(Blomstrand et al., 1989; Parry-Billings et al., 1990). In the CHO+ BCAA and 
BCAA trials however, the TRP:BCAA ratio did not change, for the duration of these 
trials. This suggests that an increased tryptophan transport into the brain occurred, 
resulting in an increased brain serotonin concentration in the CHO only trial but not 
in the other two. 
The change in TRP:BCAA was brought about by a change in the serum BCAA 
concentrations only, as total serum tryptophan concentrations did not change in any 
of the three trials (Fig 4.2). Average serum BCAA concentrations fell by between 
26% (leucine) and 31 % (isoleucine) (Fig 4.3) in the trial where a 10% carbohydrate-
only (CHO) supplement was ingested ~0.05). 
Total serum tryptophan was measured in this study as there is still a degree of doubt 
as to whether it is serum total or free tryptophan that determines the passage of 
tryptophan into the brain (Knott and Curzon, 1972; Fernstrom et al., 1976; Chaouloff 
et al., 1986). Previous studies investigating tryptophan metabolism, have measured 
either free or total serum tryptophan concentration with different results. For 
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example, Chauoloff et al. (1986), measured plasma total tryptophan concentration, 
following prolonged exercise in rats. No change in total TRP:BCAA (0.30 to 0.28) 
occurred, but brain tryptophan concentrations increased by 80%. In another rat 
experiment, Blomstrand et al. (1989), demonstrated a 2 to 3- fold increase in plasma 
free tryptophan with an associated increase in brain serotonin concentration and 
metabolism. Similar results have been seen·in humans (Davis et al., 1992), where 
these authors measured both free and total tryptophan concentrations, following 
exercise, in a protocol similar to that of the present study (cycle at 68% VOJ. max for 
up to 255 mins.). A five- to seven-fold increase in plasma free tryptophan 
concentration occurred while serum total tryptophan did not change. The plasma free 
TRP:BCAA increased seven-fold in the placebo trial. 
It can be inferred from these data that the change in the TRP:BCAA ratio is in fact an 
underestimation of the change in the free TRP:BCAA ratio in this study which 
occurred in the present study. 
Pltysical performance 
Despite an increased serum TRP:BCAA in the CHO trial, the time taken to complete 
a 40km time trial was not different compared to the other trials where serum 
TRP:BCAA did not change. 
There are two general explanations for the lack of an improved physical performance 
in this study: 
i) either the thesis hypothesis is invalid and an increase in serum 
TRP:BCAA, and consequent increased cerebral serotonin concentrations, 
does not decrease power output following prolonged endurance exercise, 
or, 
ii) the protocol was not appropriate to test the hypothesis. 
These data suggest that the protocol did induce the necessary changes in serum amino 
acid concentrations (fig 4.4). In the CHO trial total BCAA concentration decreased 
by approximately 30% and the serum TRP:BCAA ratio increased in the CHO trial 
(25.13%), while the ratio decreased in the CHO+ BCAA (-0.48%) and in the BCAA 
trial (-13.66%). It has been suggested however that a difference of20-30% in the 
BCAA concentration is insufficient to test the hypothesis fully, and a change of 
between 8- and 16-fold in the serum TRP:BCAA ratio is required to induce changes 
in cerebral serotonin (Davis, personal communication). To resolve this issue 
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therefore, an exercise protocol is required that would induce such large changes. On 
the basis of this it is not possible to invalidate the hypothesis. 
If we assume that the protocol did induce a sufficiently large decrease in the BCAA 
concentrations to increase the serum TRP:BCAA ratio, then the reason for the lack of 
a physical or mental performance difference, is the result of an invalid hypothesis. 
This could be due to: 
i) In spite of an increased serum TRP:BCAA, brain serotonin concentration did 
not increase, or 
ii) Central fatigue did not result from an increased cerebral serotonin 
concentration, or 
iii) The nature of the high intensity exercise overrides the central fatigue caused 
by an increased cerebral serotonin concentration. 
Number (iii) can be disproved from data in this study, as there is no difference in the 
RPE for the duration of the low intensity exercise. If the high intensity exercise that 
was responsible for the lack of a response, it could be expected that the RPE would 
be higher in the CHO only trial compared to the other two. This was however not the 
case as seen in Fig 4.14. 
It must therefore be concluded that either; 
i) the change in the serum TRP:BCAA ratio was insufficient to cause an increase in 
brain serotonin, 
ii) central fatigue did not result from an increased cerebral serotonin concentration. 
Further research is required to determine which of these scenarios is responsible for 
the results obtained in this study. 
Mental performance 
Since no test has been designed specifically for the measurement of mental fatigue 
(Hosstetler, personal communication), the Sternberg reaction-time test was used. 
This test measures mental performance and it was assumed that any decrease in 
mental performance would reflect the presence of mental fatigue. 
Reaction times on the Sternberg test did not change following the prolonged exercise, 
and we must conclude that mental performance did not change as a result of the 
exercise. However large inter-individual differences may have masked changes in 
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reaction time (See section 4.24). Blomstrand et al, (1991), showed an improvement 
in mental performance post-exercise, following BCAA ingestion. These authors, 
however, made use of a different test (the Stroop colour and word association test) 
which does not measure reaction time. We chose the Sternberg test in this study as a 
measure of mental performance as we believed it would be more sensitive to the 
small changes in mental performance expected, post-exercise. In the study of 
Blomstrand et al. (1991) the mental performance test was only conducted between 
one and two hours after a standard marathon of 42.2 km. In the present study, 
however, the test was conducted immediately (within 5 minutes) after the time trial. 
The differences in the design of the two studies may explain the differences in the 
results. 
IMPROVED MENTAL PERFORMANCE FOLLOWING BCAA INGESTION 
Only one other study has previously shown an ergogenic effect of ingested BCAA's 
during exercise (Blomstrand et al., 1991). This study differed from the present study 
in that subjects ran a standard marathon (42.2km), and the performance criteria was 
the time taken to complete the race, which in all cases was less than 3 Yi hours. 
Unfortunately the authors arbitrarily subdivided the experimental group into slower 
and faster runners, and improvement was only seen in the slower runners. This 
arbitrary division has no foundation and the results are therefore disputable. 
We may speculate that the slower runners in the study of Blomstrand et al. (1991) 
were less highly trained than the faster runners. This would have influenced the 
results as the state of training significantly influences the oxidation of BCAA's 
(Einspahr and Tharp, 1989). Dohm et al. (1977) showed that the enzymes involved 
in leucine oxidation, in rat muscle, adapt to endurance training in a manner similar to 
those of fat and carbohydrate catabolism, that is activity of these enzymes increase 
and BCAA oxidation is increased. Moreover, the trained rats had a less positive 
nitrogen balance than control rats, indicating that increased protein breakdown occurs 
in trained rats. This is presumably an important training adaptation in which amino 
acids are able to provide an alternative energy source (Dohm et al., 1977). 
Trained athletes exhibit a number of important changes with regard to the 
metabolism of BCAA's: 
i) The oxidation ofBCAA's in trained subjects is higher due to an increased 
uptake into the brain which is controlled by an increased enzyme activity, but 
also by changes in insulin concentration and by skeletal muscle uptake, which 
in turn is regulated through muscle enzyme activity (Henderson et al., 1985). 
However the concentration of the three BCAA's is significantly higher in the 
plasma of trained compared to untrained individuals (Einspahr and Tharp, 
1989), and the TRP:BCAA ratio is therefore not necessarily altered, and 
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ii) The influence of the enhanced muscle enzyme activity is usually 
overshadowed by the practice of carbohydrate loading. Typically this is 
practiced by the majority of endurance athletes prior to major competition 
(McArdle et al., 1991). The intention of this practice is to maximally load the 
muscle with glycogen to prevent the development of hypoglycaemia during 
competition. A major effect of this "carbo loading" is to reduce the activity of 
the BCKA dehydrogenase enzyme (Wagenmakers et al. 1991), which 
influences the degree to which BCAA's may be oxidised by the muscle. 
In spite of there being no difference in the physical or mental performance between 
trials there was a significant difference in various metabolic parameters. Based on 
these differences it may be speculated that there might be some benefit associated 
with the ingestion of BCAA's, during prolonged exercise. In order to identify the 
potential benefits associated with the ingestion of BCAA's it is important to 
determine the source of energy in the three trials. 
Metabolism during the trials 
A surprising result was that for the duration of the BCAA trial, in spite of the absence 
of exogenous carbohydrate, cyclists were able to perform equally well compared to 
those trials where carbohydrate supplementation occurred. In the BCAA trial energy 
to maintain a high work rate was probably derived from a combination of the 
following substrates: 
CARBOHYDRATE 
Normoglycaemia was maintained for the duration of the exercise bout, in all three 
trials (Fig 4.6). The maintenance of a stable plasma glucose concentration of 5 
mmol/1, was most likely due to the consumption of a pre-exercise breakfast (see 
appendix D). 
In the CHO and CHO+ BCAA trials plasma glucose concentration increased 
significantly following the time trial. This can be attributed to an increased liver 
glycogenolysis which continued post-exercise, and was reflected in the blood sample 
withdrawn within a few minutes after the time trial. This increase in plasma glucose 
concentration did not occur in the BCAA trial, possibly as a result of a decreased 
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hepatic glucose output. A reduced hepatic glucose output is due to an exhaustion of 
liver glycogen, which was utilised throughout the BCAA trial, resulting in a 
decreased glycogenolysis toward the end of the exercise bout. In those trials where 
carbohydrate supplementation occurred the exogenous CHO allowed liver glycogen 
sparing and hepatic glucose output was maintained towards the end of the trial. 
In the BCAA trial it is likely that the majority of the plasma glucose was derived 
from activity of the glucose-alanine cycle in which alanine, a major gluconeogenic 
precursor, is produced. Alanine concentrations were the same in all three trials (Fig 
A.1 ), becoming significantly lower than resting values after 120 minutes. In order to 
accurately investigate the contribution of alanine to gluconeogenesis it will be 
important for future studies to follow changes in alanine turnover throughout the 
exercise bout. 
At this stage we may only speculate about metabolic fluxes, because only serum 
concentrations were measured in this study. In the BCAA trial it is likely that an 
increased oxidation ofBCAA's to the BCKA's occurred. Associated with this 
glutamate and pyruvate combine to produce a ketogluterate and alanine (Fig 2.2). 
Alanine is then transported to the liver, where glucose is synthesised. An increased 
gluconeogenesis in this trial might explain why no differences were seen in serum 
alanine, glutamate and glutamine concentrations. In addition, the expected increase 
in the ammonia concentration in this trial, due to an increased amino oxidation, may 
have been prevented by an increased amino acid conversion to glucose (Fig 4.5). 
Serum insulin concentration decreased in all three trials post-exercise. This decline 
in serum insulin during prolonged exercise is expected (McArdle et al., 1991). The 
decline in serum insulin, during exercise, is mediated through an increased a-
adrenergic input to the P cells of the pancreas (McArdle et al. 1991 ), which overrides 
the usual stimulatory effects of plasma glucose and amino acid concentrations. Davis 
et al. (1992) found a gradual decrease in the insulin concentration over time, but 
insulin concentration was significantly higher in the two carbohydrate trials (subjects 
ingested 6% and 12% CHO solutions), compared to the placebo trial. In the CHO 
trials a significant decrease in the plasma concentration of the BCAA's occurred 
following the ingestion of two carbohydrate solutions (6% and 12%). These authors 
suggest that an increased insulin concentration is responsible for the increased uptake 
of amino acids. In the present study, though, insulin concentration did not di.ff er 
significantly in any of the three trials, suggesting that another mechanism may be 
responsible for the decreased serum BCAA concentrations. 
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The discrepancy in the insulin response in this study and the study of Davis et al. 
(1992) may be related to the fact that subjects in this study where fed, while those in 
the study Davis et al. (1992) were fasted. Inconsistencies between the two studies 
did not appear to be to related to differences in exercise intensity (insulin decreased 
to a minimum during the low intensity exercise), or in exogenous carbohydrate 
supply, which was similar in both trials (10% in the present study vs. 6% & 12% in 
Davis et al. 1992). 
It may be that some carbohydrate is required to oxidize amino acids, as a similar 
phenomenon has been shown to occur in fat oxidation where endogenous FF A's are 
not oxidised unless carbohydrate is available. It therefore appears that both fat and 
amino acid oxidation requires the presence of carbohydrate. 
FAT 
In the BCAA trial, endogenous fat stores were used to a greater extent to provide . . 
energy, compared to the other trials. This is evidenced by a higher serum free fatty 
acid (Fig 4.8) and glycerol (Fig 4.9) concentration in this group. 
This is consistent with data from Davis et al. (1992) where FF A concentrations in the 
placebo trial increased significantly compared to the other two trials. In addition, 
RER in the present study was significantly lower in the BCAA trial (p$0.05, Fig 
4.13), compared to the other two trials, indicating a greater FF A oxidation. 
PROTEIN 
Serum BCAA concentrations in the CHO trial had fallen by more than 10% after the 
first hour of exercise (Fig 4.3). This decrease, in a trial where no exogenous amino 
acids were supplied, suggests that BCAA's are oxidised to some extent, even when 
alternate substrates are available. These amino acids contribute a certain amount of 
energy to maintain the work rate throughout exercise (Dohm et al., 1977; Brooks, 
1987). It has also been proposed that oxidation of amino acids serves a number of 
functions (see section 2.21), and for this reason they may still be oxidised in the 
presence of carbohydrate. 
AMMONIA 
The changes in plasma ammonia concentration are difficult to explain. Since the 
concentration of plasma ammonia, and not turnover, was measured it is not possible 
to report on the rates of ammonia production and utilisation. In spite of this it 
appears that the ammonia concentration may provide some important clues 
concerning BCAA metabolism during exercise in trained individuals. 
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Plasma ammonia concentration following the time trial, increased significantly in 
both the CHO and CHO + BCAA trials, but not in the BCAA trial (see Fig 4.5). 
Because amino acids are the only source of exogenous energy in the BCAA trial, and 
as one of the by-products of amino acid oxidation is ammonia, it would be reasonable 
to assume that plasma ammonia concentrations would increase more in the BCAA 
trial, compared to the other two trials. This, however, did not occur. 
Because plasma ammonia concentration is proportional to exercise intensity, a 
possible explanation for the lower plasma ammonia concentration in the BCAA trial 
might be that subjects were not able to cycle at a high intensity in this trial, and 
plasma ammonia concentrations failed to increase because of the decreased exercise 
intensity. This however did not occur, as physical performance, average and 
maximal heart rates were similar during the_time trial, in all three trials (see Table 
4.3, Fig 4.15 and Fig 4.16 (pg. 59 & 66) during the time trial. There must, therefore, 
have been an alteration in metabolism to account for this discrepancy. 
During exercise ammonia is derived from two main sources; 
i) The purine nucleotide cycle (PNC). Here the reaction that is relevant to the 
present study is the is the deamination of AMP to IMP with the concomitant 
r~lease ofNH4+ (Fig 4.17). It is unlikely that the ingestion ofBCAA's would 
induce a change in the PNC (as shown in Fig 4.17), and this cannot therefore 
explain the differences in plasma ammonia concentration. The differences 
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FIGURE 4.17 A schematic representation of the formation of ammonia by the 
purine nucleotide cycle (Newsholme and Leech, p 384, 1984.) 
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ii) In certain conditions ammonia may be derived from the oxidation of amino 
acids (Brooks, 1987). Ammonia production as a result of amino acid 
oxidation is less definite, however, and is a subject of some debate. 
However, given the data in this study, it is not possible to come to any conclusions 
regarding metabolism of ammonia in the BCAA trial, and further research is required 
to identify the dynamics of the fluxes in the ammonia concentrations in the three 
trials. 
These findings do however have practical importance as a high concentration of 
plasma ammonia, during exercise, has been associated with fatigue (Banister and 
Cameron, 1990) and muscular cramps (Green, 1987). Therefore if plasma ammonia 
concentrations are decreased, as they are following BCAA ingestion, then fatigue 
may be delayed or muscle cramps may be prevented. This is discussed in more detail 
later (See potential benefits of BCAA supplementation). 
Changes in urinary urea 
During the exercise bout urinary urea excretion increased significantly in the CHO+ 
BCAA and BCAA trials, suggesting increased protein degradation compared to the 
CHO trial where urea excretion did not increase. This suggests that oxidation of 
amino acids is enhanced in the two trials where exogenous BCAA's were supplied. 
This result, however, appears to be incompatible with the ammonia data; for example 
urea excretion does not change during exercise whereas plasma ammonia 
concentrations increase 3-fold in the CHO trial, while urea excretion increases and 
plasma ammonia concentration remains low in the BCAA trial. 
76 
Wolfe et al. (1982), have proposed that the indirect measurement of protein 
catabolism (urinary urea and creatinine) conceals many pitfalls, and this has lead to 
the confusion regarding the effects of exercise on protein metabolism. As a result of 
this, it is not possible, using urinary urea and creatinine concentrations, to accurately 
determine the source of the increased excret~d nitrogen. 
Potential benefits of BCAA supplementation 
Even though there was no improvement in physical or mental performance in this 
study following the ingestion of BCAA's, it appears that there might still be some 
benefits associated with the ingestion of a BCAA supplement during prolonged 
endurance exercise. 
DECREASED LIKELIHOOD OF CRAMPS 
The low serum ammonia accumulation following intense exercise in the BCAA trial 
requires more attention as Brouns and co-workers (1990) have suggested that muscle 
cramps, during intense exercise, seems to be related to high ammonia levels and not 
potassium, lactate or glycogen concentrations. Moreover, elevated blood ammonia 
concentration is known to cause dysfunction in the central nervous system, either by 
acting directly on selected centres or by altering the brain permeability to certain 
amino acids involved in neurotransmission (Green, 1987). Furthermore, Banister and 
Cameron (1990) have suggested that a consequence of high plasma ammonia 
concentrations is that more ammonia crosses the blood-brain barrier, causing fatigue. 
I 
Data from the present study seems to indicate that all of these effects may be reduced 
ifBCAA's are ingested during exercise, since the serum ammonia concentration does 
· not increase as exercise duration progresses. However, most athletes ingest 
carbohydrate during prolonged endurance exercise, in order to delay fatigue, as this 
has been shown to delay the depletion of liver glycogen. Therefore, studies will have 
to be conducted to determine whether the advantages of a lower serum ammonia 
concentration outweigh the disadvantage of lower liver glycogen stores, which may 
occur in the absence of exogenous carbohydrate. 
IMPROVED IMMUNE SYSTEM FUNCTIONING 
Glutamine is the primary fuel for macrophages and lymphocytes (Parry-Billings et 
al., 1990). Most glutamine is produced in skeletal muscle, and it has been suggested 
that a function of BCAA oxidation is the production of glutamine for the 
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maintenance of the immune system (Parry-Billings et al., 1990). Prolonged exercise, 
in the absence of exogenous carbohydrate or BCAA supplementation, causes plasma 
glutamine concentrations to decline, in both rats and humans (Parry-Billings et al., 
1990). In the present study, however, serum glutamine concentrations were the same 
for the duration of the exercise, in all three trials, as previously discussed. 
Parry-Billings et al. (1990) propose that the decrease in plasma glutamine following 
repeated bouts of intense training may be responsible for the immunosuppressive 
effects of exercise. This hypothesis has implications for the overtrained athlete, 
where complete recovery does not occur following intensive training. This syndrome 
is difficult to quantify, and it is possible that the measurement of plasma amino acid 
concentration may aid in confirming a diagnosis of the overtrained athlete. Indeed, 
Parry-Billings et al. (1990), has demonstrated that the plasma glutamine 
concentrations are lower in overtrained athletes compared to trained athletes. It is 
further speculated that the decreased glutamine concentrations in the plasma of 
overtrained athletes may be linked to some of the symptoms of overtraining, for 
example, upper respiratory tract infections and impaired wound healing (Parry-
Billings et al., 1990). The change in glutamine concentrations, during and after 
prolonged exercise, should be studied further as it might provide an important 
application for the ingestion of BCAA's in overtrained athletes who have 
compromised immune systems. 
Summary 
This study has investigated the implications of consuming a branched-chain amino 
acid solution during prolonged exercise. Serum BCAA concentrations decreased, as 
expected during prolonged exercise when carbohydrate alone was ingested, causing 
an increase in serum TRP:BCAA. However, after ingesting a BCAA supplement 
without carbohydrate, serum BCAA concentrations and TRP:BCAA ratio did not 
change. Neither cycling performance in a 40km time trial, or mental performance as 
measured by the Sternberg test was different in this trial compared to the CHO+ 
BCAA or CHO trials 
The results of this study illustrate that in the absence of exogenous carbohydrate a 
greater proportion of fats were oxidised for energy during exercise. It is also likely 
that a greater proportion of amino acids were oxidised in the BCAA trial, to provide 
energy during low intensity prolonged exercise, followed by a short intense 
performance trial. This is in itself surprising because it is well accepted that 
exogenous carbohydrate prolongs time to fatigue. Data from this study suggests that 
the ingestion of a BCAA supplement, sufficient to prevent the decline in serum 
amino acid concentration, did not delay central fatigue sufficiently to improve 
physical or mental performance. The BCAA supplement did however permit 
subjects to perform equally well in the 40km time trial, compared to when they 
ingested carbohydrate supplements, which is a surprising result. 
It may be concluded that: 
i) The thesis hypothesis is invalid, or 
ii) The TRP:BCAA did not increase enough to increase cerebral serotonin 
sufficiently to have any affect on physical and mental performance, in the 
CHO only trial. 
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With the data from this study we are unable to satisfactorily resolve these questions, 
and it is with these conclusions in mind that future research should be directed. 
4.5 Directions of future research: 
Although, the nature of the interaction between BCAA's and exercise is now well 
understood (Acworth,1986, Block and Buse, 1990, Blomstrand et al., 1988, 
Blomstrand et al., 1989, Brodan, 1976, Decombaz et al., 1979, Einspahr and Tharp, 
1989, MacLean et al., 1991, Newsholme et al. , 1991), certain questions remain 
unanswered. 
i) It was speculated in this study that the TRP:BCAA change may not be sufficient 
to produce a large enough change in cerebral serotonin concentrations. 
Therefore a study must be conducted where increasingly larger doses of B<;AA's 
are supplemented producing systematically larger changes in TRP:BCAA. 
ii) The stable serum ammonia concentration after prolonged exercise in the BCAA 
trial has practical importance. Therefore a study investigating the rates of 
ammonia utilisation and production, following BCAA supplementation is 
required. 
iii) Serum glutaroioe changes, after prolonged exercise, are also important as 
decreases in this amino acid may cause many symptoms of overtraining. If it can 
be shown that serum glutamine concentrations increase following BCAA 
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FIGURE A. I. Percentage change in alanine concentration. Alanine 
concentration decreases in all three trials, and this becomes 
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FIGURE A.3 The absolute change in glycerol concentration. * indicates a 
significant difference in glycerol concentration in the BCAA trial compared 
to the two other trials p::;(). 05). 
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TABLE A.I Plasma amino acid concentrations (mmolll) throughout a five hour cycle. 
Amino acid concentrations were measured in eight subjects completing three trials, 
while ingesting different drinb. 
Amino TUDC (minutes) 
Trial Acid 0 60 uo I!IU 240 300 
CHO ASP 0.019 ± 0.012 0.013 ± 0.006 o.ots ± 0.008 0.013 ± 0.003 0.011 ± 0.004 0.013 ± 0.004 
GW 0.034 ± 0.009 0.023 ± 0.004 0.022 ± 0.005 0.023 ± 0.006 0.022 ± 0.005 0.027 ± 0.008 
ASN 0.053 ± 0.015 0.043 ± 0.008 0.046 ± 0.022 0.037 ± 0.006 0.035 ± 0.003 0.032 ± 0.007 
SER 0.120 ± 0.018 0.112 ± 0.019 0.119 ± 0.027 0.106 ± 0.019 0.098 ± 0.009 0.095 ± 0.013 
ms 0.079 ± 0.013 0.077 ± 0.019 0.071 ± 0.010 0.067 ± 0.012 0.069 ± 0.009 0.068 ± 0.010 
GIN 0.490 ± 0.059 0.472 ± 0.061 0.470 ± 0.067 0.460 ± 0.059 0.457 ± 0.058 0.475 ± 0.084 
GLY 0.234 ± 0.045 0.235 ± 0.050 0.184 ± 0.088 0.211 ± 0.045 0.198 ± 0.043 0.197 ± 0.045 
TifR 0.162 ± 0.042 0.155 ± 0.040 0.119 ± 0.060 0.136 ± 0.020 0.136 ± 0.020 0.134 ± 0.028 
ARG 0.067 ± 0.014 0.058 ± 0.010 0.054 ± 0.008 0.052 ± 0.008 0.051 ± 0.009 0.054 ± 0.013 
AIA 0.475 ± 0.051 0.425 ± 0.064 0.358 ± 0.050 0.299 ± 0.046 0.269 ± 0.052 0.333 ± 0.103 
1YR 0.088 ± 0.027 O.D75 ± 0.016 0.072 ± 0.012 0.066 ± 0.008 0.068 ± 0.010 0.082 ± 0.015 
VAL 0.450 ± 0.085 0.403 ± 0.071 0.373 ± 0.062 0.320 ± 0.150 0.332 ± 0.079 0.340 ± 0.085 
TRP 0.073 ± 0.016 0.063 ± 0.009 0.061 ± 0.010 0.065 ± 0.014 0.067 ± 0.013 0.069 ± 0.021 
PHE 0.082 ± 0.021 0.072 ± 0.015 0.067 ± 0.015 0.067 ± 0.013 0.066 ± 0.012 O.Q78 ± 0.020 
ILE 0.094 ± 0.033 0.077 ± 0.023 0.068 ± 0.017 0.068 ± 0.017 0.058 ± 0.015 0.066 ± 0.019 
LEU 0.181 ± 0.057 0.163 ± 0.045 0.134 ± 0.035 0.140 ± 0.028 0.122 ± 0.026 0.134 ± 0.041 
LYS 0.096 ± 0.026 0.081 ± 0.022 0.087 ± 0.022 0.086 ± 0.024 0.068 ± 0.007 0.071 ± O.Q38 
CHO+ ASP 0.010 ± 0.004 0.007 ± 0.002 0.009 ± 0.003 0.009 ± 0.003 0.011 ± 0.004 0.012 ± 0.004 
BCAA GW 0.021 ± 0.006 0.018 ± 0.004 0.018 ± 0.004 0.018 ± 0.004 0.023 ± 0.010 0.028 ± 0.012 
ASN 0.048 ± 0.010 0.041 ± 0.008 0.036 ± 0.005 0.034 ± 0.005 0.034 ± 0.004 0.033 ± 0.005 
SER 0.120 ± 0.014 0.107 ± 0.014 0.103 ± 0.016 0.101 ± 0.015 0.098 ± 0.015 0.099 ± 0.016 
ms 0.072 ± 0.010 0.071 ± 0.009 0.064 ± 0.008 0.064 ± 0.008 0.066 ± 0.010 0.067 ± 0.009 
GIN 0.518 ± 0.051 0.499 ± 0.051 0.471 ± 0.051 0.469 ± 0.057 0.457 ± 0.051 0.478 ± 0.062 
GLY 0.233 ± 0.056 0.221 ± 0.043 0.210 ± 0.044 0.201 ± 0.042 0.195 ± 0.034 0.165 ± 0.084 
TifR 0.157 ± 0.028 0.150 ± 0.031 0.136 ± 0.028 0.130 ± 0.018 0.124 ± 0.015 0.105 ± 0.055 
ARG 0.064 ± 0.011 0.061 ± 0.011 0.055 ± 0.011 0.053 ± 0.011 0.052 ± 0.011 0.052 ± 0.013 
AIA 0.483 ± 0.063 0.438 ± 0.060 0.350 ± 0.051 0.304 ± 0.043 0.267 ± 0.042 0.358 ± O.D75 
1YR 0.084 ± 0.021 O.D75 ± 0.018 0.065 ± 0.015 0.064 ± 0.017 0.067 ± 0.017 0.082 ± 0.021 
VAL 0.447 ± 0.080 0.486 ± 0.083 0.470 ± 0.059 0.477 ± 0.063 0.465 ± 0.070 0.447 ± 0.039 
TRP 0.067 ± 0.010 0.063 ± 0.009 0.059 ± 0.008 0.059 ± 0.008 0.064 ± 0.011 0.066 ± 0.018 
PHE 0.073 ± 0.014 0.066 ± 0.008 0.059 ± 0.008 0.059 ± 0.008 0.063 ± 0.010 0.081 ± 0.016 
ILE 0.094 ± 0.031 0.089 ± 0.023 0.077 ± 0.018 0.073 ± 0.018 0.070 ± 0.017 0.071 ± 0.014 
LEU 0.179 ± 0.053 0.177 ± 0.045 0.158 ± 0.027 0.149 ± 0.032 0.143 ± 0.024 0.139 ± 0.025 
LYS 0.106 ± 0.019 0.096 ± 0.015 O.Q75 ± 0.016 0.067 ± 0.015 0.072 ± 0.014 0.054 ± 0.026 
BCAA ASP 0.012 ± 0.005 0.010 ± 0.002 0.010 ± 0.003 0.010 ± 0.004 0.010 ± 0.004 0.013 ± 0.006 
GW 0.028 ± 0.006 0.019 ± 0.004 0.021 ± 0.008 0.020 ± 0.008 0.017 ± 0.005 0.019 ± 0.009 
ASN 0.045 ± 0.007 0.041 ± 0.006 O.Q35 ± 0.004 0.033 ± 0.005 0.031 ± 0.004 0.030 ± 0.003 
SER 0.120 ± 0.013 0.111 ± 0.013 0.108 ± 0.017 0.102 ± 0.014 0.094 ± 0.013 0.090 ± 0.011 
ms 0.074 ± 0.007 0.076 ± 0.015 0.071 ± 0.010 0.071 ± 0.008 0.074 ± 0.019 0.065 ± 0.008 
GIN 0.470 ± 0.058 0.465 ± 0.044 0.462 ± 0.045 0.456 ± 0.054 0.466 ± 0.045 0.441 ± 0.069 
GLY 0.212 ± 0.103 0.193 ± 0.085 0.210 ± 0.028 0.167 ± 0.071 0.188 ± 0.031 0.172 ± 0.031 
TifR 0.134 ± 0.062 0.127 ± 0.060 0.142 ± 0.036 0.123 ± 0.057 0.131 ± 0.023 0.115 ± 0.020 
ARG 0.061 ± 0.011 0.057 ± 0.012 0.053 ± 0.008 0.050 ± 0.009 0.049 ± 0.006 0.054 ± 0.016 
AIA 0.443 ± 0.071 0.402 ± 0.060 0.331 ± 0.057 0.286 ± 0.047 0.258 ± 0.041 0.317 ± 0.057 
1YR 0.082 ± 0.018 0.073 ± 0.016 0.070 ± 0.014 0.069 ± 0.009 0.068 ± 0.010 O.Q78 ± 0.008 
VAL 0.461 ± 0.070 0.508 ± 0.060 0.507 ± 0.062 0.510 ± 0.062 0.481 ± 0.059 0.553 ± 0.205 
TRP 0.074 ± 0.012 0.068 ± 0.007 0.067 ± 0.009 0.065 ± 0.009 0.065 ± 0.007 0.066 ± 0.014 
PHE O.D75 ± 0.014 0.068 ± 0.009 0.065 ± 0.009 0.066 ± 0.010 0.064 ± 0.008 0.074 ± 0.011 
ILE 0.087 ± 0.027 0.085 ± 0.021 0.077 ± 0.019 0.073 ± 0.017 0.069 ± 0.016 0.073 ± 0.014 
LEU 0.174 ± 0.047 0.176 ± 0.030 0.159 ± 0.026 0.156 ± 0.025 0.157 ± 0.022 0.158 ± 0.020 
LYS 0.098 ± 0.011 0.093 ± 0.025 0.084 ± 0.019 O.D78 ± 0.021 0.050 ± 0.024 0.071 ± 0.021 
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Appendix B - Borg Scale of Perceived Exertion 
0 None 
0.5 Very very little 
1 Very little 
2 Little 
3 Moderate 
4 Somewhat strong 
5 Strong 
6 
7 Very strong 
8 
9 
10 Very very strong 
maximal 
Appendix C - Reagents 
Drabkin's solution. 
• 0.2gKCN 
• 0.2g K3Fe(CN)6 
• l.Og NaHC03. 
This is constituted in one litre of double distilled deionised water. 
HPLC reagents. 
• Solvent A: water/stock sodium proprionate/acetonitrile (72/20/8 by vol.) 
pH=6.50 ± 0.1 at room temperature. 
• Solvent B: water/acetonitrile/methanol (45/30/25 by vol.) 
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Appendix D - Breakfasts 
Option 1 
i) Banana shake, with 2 cups skim milk and 2 large bananas 
ii) 4 slices-whole wheat toast 
iii) 3 teaspoons peanut butter 
Option 2 
i) I cup cooked oats, with 4 tablespoons raisins and half a cup skim milk 
ii) 6 provitas and 3 teaspoons margarine 
iii) Half tub fat free cottage cheese 
iv) coffee with half a cup skim milk 
Option 3 
i) I cup fruit juice (unsweetened) 
ii) I cup fruit salad (unsweetened) 
iii) I cup low fat muesli 
iv) I fat free, sugar free yoghurt 
v) I whole wheat roll 
YD. Half an avocado pear 
vii) Cocoa with I cup skim milk 
Each of the three breakfasts contain 823 kcal, 144g of carbohydrate, 28g of protein 
and 15g of fat. 
The breakfasts contained 70% carbohydrate, 14% protein and 16% fat. 
Each subject ate the same breakfast each morning preceding the exercise trial. 
